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The genome structure of Mycobacterium tuberculosis is strongly clonal, in the absence 
of horizontal gene transfer. Thus it is feasible that clonal lineages may exhibit 
particular phenotypic characteristics, which may, in turn, result in differences in 
virulence or influence their association with particular host populations. Indeed, the 
global distribution of M. tuberculosis strains is not uniform and certain strain lineages 
predominate in particular geographical areas. Further, there is evidence that some 
strain lineages are emerging, suggesting differences in virulence.  
Firstly, we investigated the association between strain genotype of M. tuberculosis and 
in vitro correlates of virulence such as growth phenotype and cytokine induction in the 
monocyte-derived macrophage (MDM) model. We report that ‘modern’ clinical M. 
tuberculosis isolates from Cape Town (Lineage 2 and Lineage 4 strains) exhibit both 
lineage-specific patterns of growth in vitro (in broth and MDM) as well as cytokine 
responses in MDM.  
Secondly, in order to study the interaction between host genetic background and the 
innate immune response to different strains of M. tuberculosis we conducted a cross 
sectional study comparing cytokine responses to in vitro infection of healthy donor 
MDM from individuals from different population groups with strains from different M. 
tuberculosis lineages. The inflammatory cytokines TNF, IL-12p40, IL-6, IL-1 and GM-
CSF were secreted at higher levels in response to infection with lineage 4 and lineage 3 
strains as compared to lineage 2 and lineage 1 strains. Principal component analysis 















CSF) to be differentially secreted in all four-population groups. In addition, we noted 
evidence of possible strain lineage-host ethnicity interactions for several cytokines. 
Together, these studies suggests that genetic diversity of M. tuberculosis might 
influence the early innate immune response during tuberculosis infection, and that 
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 1.1 Introduction 
 
Despite available anti-tuberculosis drugs and widespread vaccination, there were an 
estimated 1.7 million deaths caused by tuberculosis globally in 2009 and most of the 
cases were reported from developing countries1. In 2010, it was reported that the 
incidence of tuberculosis was 340 cases per 100,000 population per year in Africa 
(Figure 1.01)2. South Africa has the 2nd highest global tuberculosis incidence with 981 
tuberculosis cases per 100,000 people in 20102, 3. 
  
Figure 1.01 Worldwide estimation of TB incidence rates in 2010. Map showing total   number 
of estimated new tuberculosis cases per 100,000 populations during 2010. The map illustrates 
the highest incidence of tuberculosis occurrence is in sub-Saharan-African countries (WHO, 
2010).  
Although, Mycobacterium tuberculosis is the major causative agent of tuberculosis, 
other mycobacteria forming part of the M. tuberculosis species complex including M. 















suggests that M. tuberculosis is an ancient pathogen, which infected early hominids in 
East-Africa, as long as three million years ago6.  
The majority of tuberculosis cases remain asymptomatic (i.e., latent tuberculosis), 
where the immune system controls the infection and no symptoms of active disease 
are observed7. In HIV-uninfected individuals one in ten of these latent infections 
develops active tuberculosis disease7, indicating that human protective immunity does 
not completely eradicate the bacillus from the body but is sufficient in preventing the 
development of tuberculosis disease in most individuals. 
The success of M. tuberculosis in the human population is likely to be due, in part, to the 
successful evolution of M. tuberculosis to adapt to the human host; in particular, to the 
ability of the organism to evade or subvert the host immune response8-11.  
1.2 The innate immune response in tuberculosis 
 
Both innate and adaptive immunity play important roles in M. tuberculosis infection. 
The innate immune response involves immediate phagocytosis of the bacilli upon 
infection together with the interaction of M. tuberculosis with various innate receptors 
and their activation. The adaptive immune response includes both cellular and 
humoral components. The interaction with T lymphocytes is thought to be of primary 
importance in the control of mycobacterial infection. Clonal expansion of T 
lymphocytes is important for the induction of an effective adaptive immune response 
by effector T cells. However, during M. tuberculosis infection, the onset of the T cell 
mediated acquired immune response is delayed. This delay permits bacteria to adapt 
to the infection site and modulate the T cell response12. In contrast, the innate immune 















induction of adaptive immunity by T lymphocytes. Hence, it is clear that the innate 
immune system has a vital role in host defence and early control of infection. 
M. tuberculosis uses the lung as the main port of entry and major site of replication. The 
macrophage is one of the principal innate immune components of the lung in human M. 
tuberculosis infection. The macrophage and its interaction with M. tuberculosis are 
central to the pathogenesis of human TB. 
Upon inhalation of tubercle droplet nuclei, M. tuberculosis travels through respiratory 
tract and enters the lungs where it comes in contact with resident alveolar 
macrophages. Receptor mediated recognition of M. tuberculosis by alveolar 
macrophages initiates phagocytosis of infected mycobacteria. The ingested 
mycobacteria multiply inside the alveolar macrophages leading to rupture of the 
infected cells and the release of numerous bacilli. This aids early proinflammatory 
cytokine induction and recruitment of monocyte derived macrophages and other 
inflammatory cells from the blood stream into the lungs. Subsequently, extracellular 
mycobacteria multiply inside these cells and spill over from local infection site to 
neighbouring tissues and are carried to regional lymphnodes. After approximately 3 
weeks post infection T cells immunity emerges which activates macrophages by 
production of inflammatory cytokines (TNF and IFN- ) and thereby decreases 
bacterial multiplication. In time, the growth of mycobacteria is contained by 
‘granuloma’ formation which triggers dormancy or latency of mycobacterial infection. 
A ‘granuloma’ consists of  small numbers of infected phagocytes surrounded by blood 
derived monocytes, macrophages, epitheloid cells (differentiated macrophages) or 
foamy macrophages and CD4+, CD8+ lymphocytes along with fibroblasts and 
extracellular matrix protein. A characteristic feature of granulomas in tuberculosis 















responses to M. tuberculosis-derived antigens may sterilize granulomas. Alternatively, 
the lesion may reactivate years after primary exposure due with liquefaction of 
necrotic tissue (Caseous necrosis) and destruction of lung tissue, resulting in entry of 
M. tuberculosis into the lung airspaces or blood vessels and result in further 
tuberculosis disease dissemination.  The clinical consequences of M. tuberculosis 
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The innate immune response is mediated by macrophages, dendritic cells (DCs), mast 
cells, neutrophils, eosinophils and Natural Killer cell (NK cells). The main role of these 
cells is to interact with the microbial pathogen and control the initial infection. This 
may involve non-specific recognition of pathogen, opsonisation, complement 
activation, phagocytosis and activation of pro-inflammatory signalling pathways and 
induction of apoptosis13. 
1.2.1 The role of the macrophage 
 
Macrophages are professional phagocytes, which are derived from monocytes and 
serve as an essential innate immune component in M. tuberculosis infection. The main 
roles of the macrophage are to destroy the pathogen by phagocytosis, to recruit other 
innate immune cells to infection sites and process and present antigen to T 
lymphocytes. Alveolar macrophages reside in lungs and are known as residential 
macrophages while monocytes travel through blood and are carried to the infection 
site to differentiate into macrophages during tuberculosis infection. Macrophages 
possess a range of receptors on the cell surface, which interact with M. tuberculosis to 
trigger early cytokine production such as IL-12 and TNF14. Macrophages can process 
the engulfed mycobacteria and present antigen to T cells, which in turn produce IFN- 
which enhances the anti-mycobacterial activity of macrophages. Macrophage - T cell 
interactions play a central role in bacterial containment during M. tuberculosis 
infection. IFN- activated macrophages show increased expression of major 
histocompatibility complex (MHC) class II molecules, which enhances antigen 
presentation. Hence, macrophages are essential in initiating the non-specific innate 















specific adaptive immune response.  However, M. tuberculosis has evolved mechanisms 
to escape the bactericidal effects of activated macrophages15. 
Generally, macrophage activation is studied in vitro by stimulation of mononuclear 
cells with microbial components or cytokines. Based on the activation pathway, human 
macrophages are differentiated into two different types: classically activated 
macrophages (M1) and alternatively activated macrophages (M2)16, 17. Classically 
activated macrophages are activated by pro-inflammatory cytokines (or T helper type 
1 (Th1) cytokines) such as TNF, IFN-, Granulocyte-Macrophage Colony-Stimulating 
Factor (GM-CSF) and bacterial cell wall component such as lipopolysaccharide (LPS). 
M1 macrophages have a bactericidal effect and produce various inflammatory 
cytokines (IL-1, TNF, IL-6, etc.) during infection. Prolonged activation of M1 
macrophages may cause tissue damage. On the other hand, alternatively activated 
macrophages are activated by anti-inflammatory or Th2 cytokines (IL-4, M-CSF, IL-10). 
Moreover, M2 macrophages are subdivided into M2a (activated by IL-4 or IL-13), M2b 
(activated by immune complex or TLR agonists, e.g. LPS) and M2c (activated by IL-10 
and glucocorticoid hormone). M2 macrophages are less bactericidal and modulate the 
immune response by producing regulatory cytokines such as IL-1018. Hence, 
macrophage activation is balanced by pro-inflammatory and anti-inflammatory 
phenomena. 
1.2.2 Recognition of M. tuberculosis by phagocytic cells 
 
The strategy of the innate immune response is to recognize conserved structures 
present on bacterial pathogens. These structures are known as pathogen associated 
molecular patterns (PAMP)19, and the receptors of the innate immune system that 















examples of PAMPs are bacterial LPS, peptidoglycan, mannans, teichoic acids, bacterial 
DNA and RNA. M. tuberculosis has a thick cell wall containing 60% lipids and 
polysaccharides, including a rich mycolic acid layer20. M. tuberculosis possesses a broad 
range of PAMPs (such as 19kDa and 24kDa lipoproteins, LprA, LprG, 
lipoarabinomannan, phosphoinositide lipoarabinomannan, triacyl lipopeptides, 
unmethylated CpG DNA), which are recognized by specific PRRs. 
M. tuberculosis may interact with different types of receptors on the surface of 
macrophages either directly through recognition of PAMP by PRR, or indirectly by 
opsonins. Receptors include toll like receptor, the mannose receptor21, the Fc 
receptor22, complement receptor23, CD14 receptor24 and scavenger receptor25. 
The role of these receptors has been partially characterized in in vitro studies of 
tuberculosis. Mycobacteria encounter many different cell types and it is likely that the 
innate recognition is achieved through a range of ligand-receptor interactions. Multiple 
receptors may synergize in M. tuberculosis recognition, depending upon the 
distribution of a specific receptors on specific cell types26. M. tuberculosis has adapted a 
unique mechanism to invade macrophages and its invasion strategy is vital in survival 
of M. tuberculosis in macrophages.  The various cell surface receptors and 
mycobacterial legends play an important role in innate immune response. The 
interaction between different mycobacterial ligands and macrophage cell surface 
receptors is therefore described in detail below. 
1.2.3 Receptors and associated ligands 
 1.2.3.1 Toll like receptors (TLR) 
Toll like receptors on macrophages and dendritic cells have been recognised as 
important receptors for mycobacterial recognition. The mammalian TLR family has 11 















mycobacterial components including lipopolysaccharide, bacterial DNA and teichoic 
acids27-30. Tuberculosis recognition involves various TLRs including TLR2/1/6 (TLR2 
is a heterodimer of TLR1 and TLR6), TLR9 and TLR427, 31 (Figure 1.03) Interaction with 
these receptors leads to triggering of signalling pathways that promote phagocytosis 
and initiates pro-inflammatory pathways that act locally and systemically. Immune 
activation through TLR stimulation may occur with or without phagocytosis. Following 
interaction with bacterial PAMP, TLR signalling pathways are activated, which are 
based on two adaptor proteins- myeloid differentiation protein 88 (MyD88) and 
Toll/IL-1R (TIR) domain containing adaptor protein inducing i terferon  (IFN) 
[TIRF]. Firstly, the MyD88 dependent pathway is a cascade of different receptors which 
are engaged in the signalling of various TLRs (except TLR3 which only activates though 
TIRF, TLR4 activates through both MyD88 dependent pathway and TRIF), leading to 
the activation of the mitogen associated protein kinase (MAPK) pathways and nuclear 
translocation transcription factors (NF-B) which in turn switches on transcription of 
different genes involved in the production of various pro-inflammatory cytokines such 

















Figure 1.03 Diagram showing interaction of mycobacterial ligands with innate 
immune receptors on macrophages and induction of associated cytokines (Redrawn 
and modified from Jo, Eun-Kyeong, 2008). 
 
Secondly, TIRF dependent pathways which are TLR4 mediated and involved in the 
activation of NF-B and interferon regulatory factor 3 (IRF-3) pathways are also 
involved in the transcription of pro-inflammatory type-I interferon32.  
1.2.3.2 Experimental studies of TLR and associated ligands  
 
M. tuberculosis possesses several lipoproteins (such as 19kDa lipoprotein, 27kDa 
lipoprotein, LprA, LprG) that interact with TLR and other receptors. Lipoprotein-
mediated recognition of TLR modulates the function of innate and adaptive immunity 
in M. tuberculosis infection. The 19kDa lipoprotein plays an important role in immune 
recognition by TLRs during tuberculosis infection. The 19kDa lipoprotein induces IL-
12p40 production by a human THP1 monocyte cell line33.  IL-12 is an important 
inducer of Th1 lymphocyte responses34 that are essential to eliminate mycobacterial 















mycobacterial activity in macrophages during tuberculosis infection. IFN- stimulated 
macrophages up-regulate MHC class II antigen processing and presentation to CD4 T 
cells and demonstrate increased bactericidal activity36. However, in humans, IFN- 
stimulated macrophages cannot completely eradicate tuberculosis infection. The 
mechanism by which tuberculosis escapes the bactericidal effect of IFN- can be partly 
explained by the effect of lipoprotein-mediated stimulation on human macrophages. 
The 19kDa lipoprotein decreases IFN- regulated antigen processing and presentation 
by HLA-DR37. FcRI is considered as a marker of macrophage activation, which is 
regulated by IFN-. The expression of FcRI was shown to be decreased following 
prolonged stimulation (>24h) of THP1 cells with 19 kDa lipoprotein and IFN- through 
a TLR-dependent pathway37. Additionally, the 24kDa lipoprotein (LPr G) was found to 
be a TLR2 antagonist and inhibited MHC class II Ag processing following prolonged 
exposure (>16h) of THP1 cells and human primary macrophages38.   
Activation of TLR receptors has been implicated in the process of autophagy. 
Autophagy is an innate immune mechanism of host defence, which involves the 
formation of a membrane around the cytosol along with infected cell organelles and 
microbial pathogens, which is further supplied to lysosome for degradation. A recent 
study using human alveolar macrophages and a RAW264.7 cell line demonstrated 
enhanced mycobacterial co-localization with the autophagosome when stimulated with 
LPS (via the TLR4 mediated and MyD88 independent signalling pathway)39. Various in 
vitro cell culture and murine studies demonstrating the role of TLRs in tuberculosis 















                             Table 1.01 In vitro studies of the role of TLR in the immune response to M. tuberculosis. 
Receptors M. tuberculosis / ligands Effect of recognition/ infection References 
Toll like 
receptor  
          TLR 2 
 
19kDa lipoprotein (P19) 19 kDa lipoprotein stimulated THP1 cell line induces IL-12 




TLR2 knockout mice showed decrease in production of pro-
inflammatory cytokines such as IL-12p40 and TNF- when 
compared with normal mice at 4 hours and 24 hours post infection. 
41 
19kDa lipoprotein (P19) 19kDa lipoprotein suppressed NO production in presence of iNOS 
inhibitor (L-NIL, N-immunoethyl-L-lysine) in M. tuberculosis infected 
RAW264.7 murine cell line, which in turn reduced antimicrobial 
activity, suggesting NO is needed in TLR mediated antimicrobial 
response. Further, 19kDa lipoprotein-stimulated M. tuberculosis 
infected peritoneal macrophages from TLR 2 Knockout mice showed 
negligible level of reduction in NO level and intracellular growth of 
mycobacteria was not affected, suggesting that the antimicrobial 
activity of TLR 2 is NO dependent in murine macrophages. 
Alternatively, human monocytes showed reduction in intracellular 
growth mycobacteria was restricted when stimulated with 19kDa 
lipoprotein in presence of a TLR2-blocking antibody while iNOS 
inhibitor has no effect on NO production or reduction in bacterial 
number, suggesting that the antimicrobial activity of TLR is NO 

















Receptors M. tuberculosis / ligands  Effect of recognition/ infection References 
TLR 2  
          19kDa-glycolipoprotein   
          (P19) 
19kDa glycolipoprotein (P19) treated THP1 cells and MDM showed 
increase in apoptosis, using Annexin V binding to membrane 
phosphatidylserine and tunnel assays. The apoptosis was TLR2 
mediated as blocking of TLR2 activity by a monoclonal antibody 
resulting in inhibition of apoptosis. 
43 
 19kDa glycolipoprotein (P19) 
& LprG 
Regulates expression of MHC II molecules and inhibition of antigen 
processing and presentation in THP1 cell line and human primary 
macrophages. Blocking of TLR2 using a monoclonal antibody 










38kDa glycoprotein-treated monocytes from pulmonary 
tuberculosis patient secreted more TNF- and IL-6 than healthy 
donors and the cytokine secretion was TLR2 and TLR4 mediated. 
The pro-inflammatory cytokine secretion was enhanced by 
activa ion of mitogen activated protein kinase and extracellular 




























        
Together, these findings suggest that interaction of TLR and mycobacterial ligands induces pro-inflammatory responses 
during ex-vivo tuberculosis infection. Furthermore, TLR knockout mice have compromised immune responses and 
increased susceptibility to M. tuberculosis infection, suggesting an important role of TLR in tuberculosis disease 
susceptibility.




M. tuberculosis infection in TLR4 




In a low dose model of bacillary infection, TLR4 deficient mice 
were more susceptible to Mycobacterium tuberculosis infection. 
TNF-, IL-12p40 and Monocyte Chemotactic Protein-1 (MCP-1) 
production in BAL supernatant and lung homogenate was lower 
in TLR4 knockout mice than wild-type mice. 
45 
 M. tuberculosis infection in TLR4 
defective mice (C3H/HeJ) and 
wild-type mice  (C3H). 
In a high dose aerosol infection, TLR4 knockout mice did 
not exhibit increased susceptibility to infection. 
 
46 
TLR9 CpG motifs in bacterial DNA 
  
 
M. tuberculosis in TLR2 and 
TLR9 double knockout mice. 
 
Induce IL-12 by dendritic cells in M. tuberculosis infected mice. 
TLR2/9 double knockout mice showed greater susceptibility to 
Mycobacterium tuberculosis infection than a single TLR knockout 
mice (TLR2 or TLR9) and marked by defects in IL-12 and other 














1.2.3.3   The role of TLR in human tuberculosis  
 
Various human investigations have revealed the pivotal role of TLR-mediated 
resistance against M. tuberculosis infection. The Vitamin D3 pathway has been 
shown to be important in the control M. tuberculosis replication in macrophages48. 
Vitamin D deficiency is considered to be a risk factor for M. tuberculosis infection49, 
50. Liu et al. showed that TLR2 mediated activation of macrophages up-regulates 
the Vitamin D receptor and Vitamin D- 1- hydroxylase genes, leading to the 
induction of the antimicrobial peptide, cathelicidin51. African American individuals 
who are more susceptible to M. tuberculosis infection have low levels of 25 
hydroxyvitamin D (a precursor of Vitamin D, also known as calcidiol), resulting in 
the reduced production of cathelicidin52. Further, a non-synonymous single 
nucleotide polymorphism (SNP), TLR1 SNP I602S (T1805G), is reportedly 
associated with differential NF-B mediated signalling in HEK293 cells in response 
to stimulation with triacylated lipopeptides from M. tuberculosis28. The T allele, 
which is highly prevalent (allelic frequency 0.99) in Vietnamese and African 
Americans (allelic frequency 0.750) compared to the European American 
population (allelic frequency 0.231), was associated with a higher level of 
inflammatory cytokine IL-6 induction in whole blood stimulated with lipopeptides, 
indicating polymorphism in TLR1 (I602S) might associate with a different 
spectrum of inflammatory responses that might be associated with the 
susceptibility to tuberculosis disease28. Subsequently, a case control study from 
Vietnam has reported an association of tuberculosis with a polymorphism in Toll 
Interleukin Receptor Domain (TIRAP- a receptor protein which is involved in TLR 
signalling during M. tuberculosis infection). The study compared patients with 
















as a control. The synonymous SNP C558T in TIRAP was associated with 
susceptibility to tuberculosis, while further genotyping frequency analysis found 
that the 558T haplotype was more frequent amongst the patients with 
tuberculosis meningitis than pulmonary tuberculosis. Additionally, the 558TT 
genotype was associated with a low level of IL-6 production in whole blood assays 
when compared with the 558CC genotype, suggesting TIRAP influenced the 
disease susceptibility by moderating inflammatory cytokine IL-6 production53. A 
recent study has shown that a SNP rs352139 in an intron of TLR9 increases 
susceptibility to tuberculosis in the Vietnamese female population, suggesting 
TLR9 polymorphisms may have a role in susceptibility to tuberculosis in the Asian 
population54. 
1.2.3.4 Mannose receptor and associated ligands 
 
The mannose receptor plays an important role in non-opsonised uptake of M. 
tuberculosis during phagocytosis and in host cell modulation. Mannosyl-
lipoarabinomannan (Man-LAM), in the mycobacterial cell wall, serves as a ligand 
for mannose receptors.  
Lipoarabinomannan (LAM) is a major cell wall component of M. tuberculosis55.  
LAM is made up of a backbone of manosyl-phosphatidyl-inositol, which is attached 
to a D-mannan core and a D-arabino domain. The arabino domains may possess 
either a capping of mannosyl (Man-LAM) or phosphoinositide (PI-LAM) or remain 
uncapped (Ara-LAM). Man-LAM is present in the slow growing virulent Erdman 
strain of M. tuberculosis and M. bovis bacillus calmette –guérin (BCG) whilst the 















PI-LAM has been found mostly in rapidly growing mycobacterial species such as M. 
smegmatis58, also in M. tuberculosis H37Rv and M. bovis BCG59. 
LAM plays a key role in receptor-mediated phagocytosis of M. tuberculosis. 
Schlesinger et al. have shown that phagocytosis of two virulent strains (H37Rv and 
Erdman) by human monocyte-derived macrophages is mediated by the mannose 
receptor in addition to complement receptors (CR1, CR3 and CR4) whereas the 
avirulent strain H37Ra interacts only with complement receptors during 
phagocytosis21. Polystyrene microspheres coated with Man-LAM were shown to 
adhere to monocyte-derived macrophages (MDMs). This was confirmed by 
abrogating the effect of Man-LAM with exomanosidase treatment of Man-LAM or 
blocking Man-LAM with monoclonal antibody, both of which resulted in the 
inhibition of adherence of mycobacteria to MDM60. 
Additionally, structural variations in LAM are associated with differential cytokine 
induction in human and murine macrophages. Ara-LAM from H37Ra induced more 
TNF production by murine macrophages and human PBMC as compared to Man-
LAM from the virulent Erdman strain of M. tuberculosis61. 
Man-LAM antagonises mannose receptor-dependent IL-12 production62. In 
contrast, PI-LAM from non-pathogenic mycobacteria (eg. M. smegmatis) was 
shown to activate murine macrophages and a human monocytic cell line by a 
TLR2-dependent pathway resulting in the induction of pro-inflammatory cytokines 
TNF-α and IL-12, which are responsible for the induction of apoptosis63-65. 
Phagocytic uptake through mannose receptors in dendritic cells is associated with 
an anti-inflammatory response due to inhibition of IL-12 production, which in turn 















virulence factor that suppresses pro-inflammatory cytokine production and 
enhances intracellular survival. 
1.2.3.5 DC-SIGN receptor 
 
The DC-SIGN receptor also plays an important role in mycobacterial recognition by 
the innate immune system. The DC-SIGN receptor is generally present on the 
surface of dendritic cells and is also expressed on the surface of macrophages and 
alveolar macrophages on exposure to microbial infection67. DC-SIGN acts as a 
major phagocytic receptor for M. tuberculosis on human dendritic cells by binding 
to Man-LAM. It specifically recognizes those mycobacterial species which contain 
Man-LAM68. The DC-SIGN receptor therefore recognizes M. bovis BCG and M. 
tuberculosis but it does not bind to mycobacterial species such as M. smegmatis. M. 
tuberculosis binds with DC-SIGN to induce the anti-inflammatory cytokine, IL-10, 
which results in the blocking of dendritic cell maturation69.  
1.2.3.6 Complement receptor 
 
The complement system is a cascade of serum proteins which are present on cell 
surfaces and activated by antibodies (classical pathway) or microbes (alternative 
pathway)70. The complement system is involved in opsonisation of invading 
bacteria, which in turn promotes phagocytosis and bacterial cell lysis. M. 
tuberculosis utilizes the complement system to invade macrophages. Macrophages 
express two-complement receptor proteins on their cell surface: CR1- a 
monovalent transmembrane protein and C3b/C4b- a heterodimer with a common 
 chain71. M. tuberculosis can be ingested by activation of complement receptors 
following opsonisation with C3b and iC3b, a derivative of C3, which permits the 















tuberculosis is capable of binding non-opsonically to CR3 in which case the 
capsular polysaccharide of M. tuberculosis binds to the  glucan-binding site on 
CR371. CR3 is therefore involved in both opsonic and non-opsonic binding of M. 
tuberculosis but the function of this receptor in mycobacterial uptake is not clear 
from human and animal studies72.  
1.2.3.7 Other receptors 
 
Apart from the above major receptors, various other receptors may take part in 
phagocytosis and innate immune recognition. For instance, CD14 has been found 
to be associated with non-opsonic uptake of mycobacteria. The neutralization of 
CD14-receptor with monoclonal antibody inhibits uptake of H37Rv in human 
microglial cells73.  Subsequently, the blocking of CRs and mannose receptors 
together with monoclonal antibodies does not completely prevent mycobacterial 
uptake in macrophages and may play a role by scavenger receptors25.   
1.3 Cytokines as mediators of the innate immune response 
 
Receptor-mediated recognition of M. tuberculosis results in cellular activation and 
production of cytokines74. Triggering of the appropriate activating receptor by M. 
tuberculosis induces transcriptional activities resulting in an early inflammatory 
cytokine response32 (Figure 1.05). This in turn induces various chemokines and 
further promotes recruitment of macrophages, neutrophils, T cells and NK cells to 
the site of infection74, 75, as part of non-specific host defence mechanisms. In turn, 
























Figure 1.04 Diagram showing activation of macrophages and dendritic cells by M. 
tuberculosis and induction of various inflammatory cytokines (Adapted and 
modified from van Crevel et al., 2002). 
1.3.1 Tumor necrosis factor (TNF) 
 
TNF is an essential pro-inflammatory cytokine, which is produced by monocytes, 
macrophages, dendritic cells, and T cells during tuberculosis infection. 
Experimental evidence suggests that TNF is an essential mediator in tubercular 
granuloma formation14, 76, 77. It has a broad range of activity including macrophage 
activation and enhancement of chemokine production. In humans, neutralization 
of TNF using anti-TNF drugs in treatment of rheumatologic diseases increases the 
risk of reactivation of latent tuberculosis, clearly indicating that TNF plays a 
protective role in tuberculosis infection78-80.  
 
 
Acute phase response 
IFNγ 
auto-induction Stimulation of IFNγ producing cells 
Macrophage/ 
Dendritic cell Initiation of adaptive 
immunity 
Chemotaxis 
TNF-α, IL-1β, IFNγ ... IL-12, IL-15, IL-18 
IL-6 ... 
MHC, CD1, CD80, IL-12, IL-18,TNF-α,IL-1β... 
















1.3.2 Interleukin-12 (IL-12) 
 
M. tuberculosis is a strong inducer of IL-12, which is mainly produced by 
macrophages and dendritic cells following phagocytosis of tubercle bacilli. IL-12 is 
essential to induce a protective Th1 response with production of IFN-34. In 
humans, mutations in the IL-12p40 and the IL-12 receptor genes result in 
enhanced susceptibility to mycobacterial infection81, 82.   
1.3.3 Interleukin-6 (IL-6) 
 
IL-6 is produced by monocytes and macrophages following phagocytosis of M. 
tuberculosis and causes inflammation and an acute phase response83, 84. However, 
IL-6 serves as a multifunctional cytokine with pro-inflammatory and anti-
inflammatory properties. For instance, IL-6 has been found to inhibit IFN- 
secretion by human and mice macrophages, suggesting IL-6 is an antagonist of 
cellular immunity85. On the other hand, IL-6 deficient mice have been shown to 
develop lethal tuberculosis infection, identifying a possible protective role of IL-6 
in tuberculosis86. 
1.3.4 Interleukin- 1 (IL-1) 
 
IL-1, an important cytokine mediator in tuberculosis infection, is produced by 
monocytes, macrophages and dendritic cells87, 88. IL-1 is involved in multiple 
activities such as inflammation, cell proliferation, differentiation, and apoptosis. IL-
1 is induced primarily in precursor form and is activated by the caspase-1 
enzyme upon bacterial stimulation. A soluble receptor, IL1Ra, acts as an antagonist 















IL1Ra polymorphisms on M. tuberculosis infection90. For instance, in vitro 
stimulation of PBMC with virulent H37Rv induced an increased level of IL1Ra 
mRNA and its protein in healthy homozygous IL1Ra A2+ subjects when compared 
to healthy IL1Ra A- individuals. The ratio of IL1Ra/IL-1 was higher in IL1Ra A2+ 
individuals90. Additionally, a case control study amongst 89 Indian emigrants in 
the United Kingdom reported that IL1Ra A2-/ IL-1 A1+, a pro-inflammatory 
haplotype (produces less IL1Ra and more IL1), was unevenly distributed 
amongst patients with tuberculosis pleurisy, resulting in reduced IL1 antagonism, 
highly delayed type of hypersensitivity (DTH) and a strong inflammatory response 
in tuberculosis pleurisy90. Furthermore, the IL1Ra A2+ homozygous genotype was 
associated with a reduced level of DTH in response to purified protein derivative 
(used for tuberculin skin testing) and was not associated with tuberculosis 
pleurisy90.  
1.3.5 Interleukin-10 (IL-10) 
 
IL-10 is a regulatory cytokine, produced by alternatively activated macrophages, 
dendritic cells and regulatory T cells, which subverts innate immunity in bacterial 
infection18, 91. Peripheral blood mononuclear cells (PBMCs) from HIV infected 
tuberculosis patients induced lower levels of IFN- as compared to HIV-uninfected 
tuberculosis patients and healthy donors. Blocking of IL-10 with a monoclonal 
antibody increased the production of IFN- and enhanced IL-12 production in HIV 
infected tuberculosis and HIV negative tuberculosis patients92. Additionally, the 
expression of the T cell stimulatory factor CTLA4 was reduced in PBMC from 
tuberculosis patients. Further, stimulation of PBMC from tuberculosis patients 















down-regulates IL-12 secretion by down-regulating CTLA4 expression, resulting in 
the suppression of the Th1 response during M. tuberculosis infection92. Evidence 
suggests that IL-10 affects the Th1 response differently with different pathogens93. 
For example, IL-10 knockout mice infected with different mycobacteria showed 
differences in bacterial clearance from various infected organs. M. avium-infected 
IL-10 knockout mice showed a sustained increase in IFN- producing T cell 
response, causing immediate clearance of M. avium from the lungs and liver. In 
contrast, M. tuberculosis-infected IL-10 knock-out mice showed a transient 
increase in the IFN- producing T cell response at 4 weeks post infection but this 
response diminished at 8 weeks and similar T cell responses were observed in 
both wild type and IL-10 knockout mice. There was reduction in bacterial number 
in lungs at four weeks post infection but bacteria were retained in the lungs and an 
equivalent amount of M. tuberculosis was recovered from lungs at 8 weeks in both 
wild type and IL-10 knockout mice. Additionally, IL-10 knockout mice showed a 
significant increase in IL-12 production at 48 hours post infection with M. avium 
but not with M. tuberculosis, suggesting endogenous IL-10 secretion by pathogenic 
mycobacteria plays a complex role in mycobacterial infection94.  
1.3.6 Chemokines 
 
Several studies have reported the important role of chemokines in the innate and 
adaptive immune response to tuberculosis95, 96. Chemokines are produced by 
monocytes, macrophages, and dendritic cells and also by CD4+ T cells. Chemokines 
influence cellular migration, recruitment, and activation of monocytes, 
macrophages, and leucocytes. Tuberculosis infection is followed by induction of 















CCL2 (macrophage chemotactic protein-1: MCP1), CCL3 (macrophage 
inflammatory protein 1-: MIP1-) and CCL4 (macrophage inflammatory protein 
1-: MIP1-)97, 98.  
CCL2/MCP-1 plays a crucial role as a chemoattractant for monocytes and T 
lymphocytes99. CCL2 mRNA and protein levels are elevated in PBMC-derived 
CD14+ cells in tuberculosis infection. Immunoblotting with anti-CCL2 antibody 
showed high levels of MCP-1 in tuberculous lymph nodes100. A study in Brazilian 
tuberculosis patients has reported that the 17q11-17q21 regions of the human 
chromosome, which possess chemokine encoding genes for CCL2 and many other 
chemokines, are associated with susceptibility to tuberculosis101. Subsequently, 
Flores et al. reported that polymorphism in CCL2 promoter (MCP-1-2518) was 
associated with active pulmonary tuberculosis disease and increased plasma CCL2 
levels in Mexican and Korean tuberculosis patients with G genotypes102. 
Tuberculosis was more common in patients with AG and GG than AA genotypes. 
Individuals with the CCL2 GG homozygous genotype showed a high level of CCL2 in 
plasma while the concentration of IL-12 was low102. Furthermore, monocytes from 
healthy carriers with the GG genotype produced more CCL2 than monocytes from 
individuals with the AA genotype, when stimulated with M. tuberculosis antigens. 
Neutralization of CCL2 activity with monoclonal antibody increased IL-12p40 in 
monocytes from the  GG genotype while addition of exogenous CCL2 increased IL-
12p40 production by monocytes from individuals with the AA genotype102.  This 
suggests that individuals with CCL2 GG genotype may have enhanced MCP1 
production, which in turn inhibits the production of IL-12p40 and increases the 















MIP1- and MIP1- are involved in the activation of macrophages103 and 
activation and proliferation of T cells99. Alveolar macrophages infected with H37Rv 
produce less MIP1- and MIP1- when compared to macrophages infected with 
H37Ra104. Additionally, alveolar macrophages from HIV infected patients have 
shown to produce reduced levels of TNF and MIP1- when compared with alveolar 
macrophages from healthy individuals104. MIP1- has been found to reduce the 
intracellular growth of M. tuberculosis104. 
Another important chemokine in M. tuberculosis infection is IL-8, which is 
primarily produced by monocytes and macrophages upon phagocytosis of tubercle 
bacilli105 and serves as a chemoattractant to recruit neutrophils, lymphocytes, and 
monocytes to sites of infection106, 107. IL-8 and other chemokine levels were found 
to be elevated in the bronchoalveolar lavage (BAL) fluid of patients with 
tuberculosis108.  
The major findings discussed in this part of the literature review clearly 
demonstrate the key role of the innate immune response in the outcome of M. 
tuberculosis infection. During course of evolution, M. tuberculosis has adapted 
various diverse mechanisms to evade host microbiocidal functions, leading to 
persistence and proliferation within favourable niches. Recognition of 
mycobacterial PAMP by different PRR phagocytic cells and their subsequent 
activation is important to switch on pro-inflammatory signalling pathways, which 
enable the effective innate immune response to mycobacteria. Virulent strains of 
M. tuberculosis modulate inflammatory response by recognition through 















of phagocytes. This ability of M. tuberculosis to modulate inflammatory cytokine 

























































2.1 Introduction  
 
It was previously believed that genetic variation in M. tuberculosis was restricted 
and M. tuberculosis was considered to be a monomorphic species109. More recently, 
studies have revealed that there is considerable variation in the genome of M. 
tuberculosis, and that evolution is based on deletion, duplication and single 
nucleotide polymorphism110-112. Horizontal gene transfer is considered to be a very 
rare event. Since genetic transfer seldom, if ever, occurs with modern TB strains5, 
M. tuberculosis follows a clonal pattern of evolution113, 114.  
The range of clinical outcomes following infection with M. tuberculosis suggests 
that genetic diversity in M. tuberculosis strains may be an important determinant 
in the development of tuberculosis disease111, 115-123. The term ‘virulence’ has many 
possible interpretations when applied to M. tuberculosis. It may be used to refer to 
lethality, to transmissibility, to a predilection for causing disease rather than latent 
infection, to a propensity for extra-pulmonary spread or the acquisition of multi-
drug resistance124-128. Since virulence is complex, and difficult to assess in the 
human host,  virulence of M. tuberculosis has been assessed in various in vivo 
animal129-131 and in vitro tissue culture models132-134, which may be used to model 
growth or dissemination, disease pathology, fatality and transmissibility. 
Importantly, different genotypes of M. tuberculosis have been shown to induce 
distinct immune-pathological responses in various animal and human studies129, 
130, 135-137. Several outbreak strains have been shown to subvert the body’s 
protective immune response with identification of specific virulence determinants 















The M. tuberculosis global phylogeny consists of six phylogeographic lineages111.  
Evidence from epidemiological studies suggests that these lineages might be 
adapted to particular human populations111, 112, 117, 141 For instance, Gagneux et al. 
observed, in a cosmopolitan setting in San Francisco, where diverse groups of 
humans and tuberculosis strain lineages co-exist, that prevalent strains were 
associated with their sympatrica  human population111. When infection with 
allopatricb strains occurred, it was mainly associated with risk factors such as HIV-
TB co-infection, which perturb the normal host-pathogen relationship111.  
The question therefore arises whether differences in virulence may be ascribed 
broadly to M. tuberculosis strain lineages, or whether such differences exist only at 
the level of the individual strain. This review will describe the consequences of 
genetic diversity between M. tuberculosis str in lineages and the associated 
virulence characteristics that have been assessed previously in various studies in 
human tissue culture and animal models.  
2.2 Molecular typing to detect genetic diversity in M. tuberculosis 
 
 In past years, the identification of diversity within the M. tuberculosis complex 
(MTBCc) was restricted to morphological characteristics, growth phenotype and 
biochemical characteristics142. These techniques were highly laborious, time 
consuming and poorly discriminatory.  
Molecular biological techniques such as whole genome sequencing, restriction 
fragment length polymorphism (RFLP) analysis, spoligotyping, Mycobacterial 
                                                             
a Occupying the same geographical location 
b Occupying different geographical locations 
c MTBC : Mycobacterium tuberculosis complex, including M. tuberculosis, M. africanum, M. bovis and      
















Interspersed Repetitive Units-Variable Number Tandem Repeat (MIRU-VNTR) and 
deletion analysis have provided the opportunity to analyse genetic variation in 
different M. tuberculosis isolates and contribute to the construction of a global 
phylogenetic classification of M. tuberculosis. Moreover, these genotyping 
techniques have proven useful in tuberculosis control efforts by identifying clonal 
outbreaks, distinguishing between reactivation and reinfection and in mapping 
transmission within communities143-146. 
2.2.1 IS6110 restriction fragment length polymorphism 
 
Insertion sequences (IS) are generally small DNA sequences (less than 2.5 kb) 
distributed through the bacterial genome as mobile genetic elements. The most 
commonly found IS element in MTBC is IS6110, a 1355 bp insertional sequence of 
the IS3 family, and is exclusively present within the MTBC147. IS elements have two 
particular characteristics: they code for a protein (usually denoted as transposase) 
which catalyses the enzymatic reaction to promote movement of the IS element 
throughout the bacterial genome as well as one regulatory protein which regulates 
transposition activity. Transposition of IS elements can cause gene disruption and 
activation or change of the adjacent gene expression due to the presence of 
included regulatory elements. IS elements are important from an evolutionary 
perspective. IS elements can act as  genome parasites to harm the host  bacteria148 
but  also play an important role in bacterial adaptive evolution149. 
In 1993, Van Embden et al. developed a restriction fragment length polymorphism 
(RFLP) analysis incorporating restriction digestion by the enzyme PvuII followed 
by Southern blotting and hybridization with a probe for IS6110150. This method is 















studies in the past have reported that RFLP has important advantages in terms of 
stability, reproducibility and high discriminatory value152, 153. MTBC members 
possess between 0 and 25 copies of IS6110154, 155. RFLP has low discriminatory 
power for M. tuberculosis strains that contain five or fewer copies of IS6110156. 
Further disadvantages of RFLP are that it is a slow, time consuming, labour 
intensive and technically demanding technique which requires large amounts of 
DNA from mycobacterial isolates. 
2.2.2 Spoligotyping 
 
The M. tuberculosis genome shows diverse repetitive sequences: transposable 
elements147, trinucleotide repeats157, mycobacterial interspersed repetitive units 
variable number tandem repeats114,158 and the direct repeat (DR) region159. The DR 
region in M. tuberculosis comprises multiple 36bp direct repeat sequences which 
are interspersed with 35 to 41bp unique spacer DNA sequences. The number of 
repeats in a DR sequence varies from 10 to 50 in various strains within the M. 
tuberculosis complex. The DR region is one of the most extensively studied loci for 
studying strain diversity amongst MTBC. 
Spoligotyping is a combination of polymerase chain reaction (PCR) and 
hybridization techniques which identify the presence or absence of 43 
interspersed spacer sequences in the DR regions of different strains of M. 
tuberculosis. The first step in this method is to amplify the DR regions using  
primers directed at the DR sequences which also amplify the adjacent spacer 
region present between two DR loci. The presence or absence of a spacer sequence 
in a test strain is determined by hybridization to a membrane coated with 43 















Hybridization is detected by chemiluminescence. Spoligotyping results are highly 
reproducible; data can easily be allocated numerical values and computerized and 
are available for interlaboratory comparison. An international spoligotyping 
database (SpolDB4) has been developed which includes at least 39,295 entries 
from 122 countries160. The groups of isolates are assigned into different clades or 
families based on the similarity in spoligotyping pattern.  Spoligotyping is typically 
performed from cultured isolates but can also be performed directly from some 
clinical samples without prior culturing, as well as from paraffin-embedded 
material and Ziehl-Neelson stained slides. Spoligotyping can also be useful to 
differentiate various species of the MTBC depending on the species-specific 
variation of spacer sequences. The major limitations of spoligotyping are a 
relatively low discriminatory power, and the possibility of convergent evolution 
giving rise to identical or similar spoligotype patterns in strains which are only 
distantly related161. 
2.2.3 Mycobacterial interspersed repetitive unit- variable number tandem  
repeat (MIRU-VNTR) genotyping 
 
The genome of M. tuberculosis contains diverse repetitive sequences including 
several short nucleotide sequences which are structured as tandem repeats and 
often exhibit a variation in repeat number (known as variable number tandem 
repeat [VNTR]). Earlier, systematic analysis of MTBC strains described 11 loci 
comprising five major polymorphic tandem repeats (MPTR, A to E) and six exact 
tandem repeats (ETR, A to F, 53-79bp)158. Supply et al. recognized the presence of 
human minisatellite-like structures in the genome of MTBC. The minisatellite 
structures consist of 40-100bp repetitive sequences called Mycobacterial 















chromosome of M. tuberculosis H37Rv114. Initially, 12 MIRU within the 41 loci were 
reported to be highly polymorphic and suitable for strain genotyping114. The 
MIRU-VNTR genotyping method is based on the detection of  the  number of 
tandem repeats at several loci in the  M. tuberculosis genome. One commonly used 
MIRU-VNTR method for typing M. tuberculosis clinical isolates is based on the 
detection of 12 of the 41 MIRU loci. MIRU-VNTR involves PCR amplification of each 
of these 12 loci to determine the size of the amplicon and hence the number of 
repeats at each locus. This is denoted by a 12 digit format corresponding to the 
number of repeats at each locus. It has been reported that 12-locus MIRU is less 
discriminatory compared to IS6110-RFLP typing with high IS6110 copy number 
strains162. More recently, additional loci have been included in the MIRU-VNTR 
typing method, e.g., 24-locus MIRU-VNTR163. 
2.2.4 Large Sequence Polymorphisms 
 
Fleischmann et al. performed comparative analysis on the genome sequences of 
H37Rv and CDC1551 and identified single nucleotide polymorphisms (SNPs) and 
deletions in the coding sequences, the latter of which are known as large sequence 
polymorphisms (LSPs) or regions of difference (RD)164. LSPs have been identified 
throughout the M. tuberculosis genome and are irreversible and aggregative in 
nature. Various studies have used deletion mapping to distinguish between strains 
within the MTBC111, 165, 166. LSPs were used by Gagneux et al.  to construct a global 
















Figure 2.01 Global phylogeny of M. tuberculosis based on large sequence 
polymorphisms. (Taken directly from Gagneux et al., 2006). 
  
2.2.5 Single nucleotide polymorphisms 
 
Since, in general, the genome structure of MTBC is highly conserved, 
polymorphism at the nucleotide level is an important source of genetic variation in 
mycobacteria as well as a useful  tool for detecting strain diversity in MTBC. Non-
synonymous SNPs (nsSNPs) alter the single amino acid sequence and may confer a 
specific phenotypic characteristic such as drug resistance110. Synonymous SNPs 
(sSNPs) are useful to study bacterial evolution and genetic drift amongst M. 
tuberculosis strains. Various studies have used SNPs as a basis for phylogenetic 
analysis109, 112, 167 including an important recent global phylogeny by Hershberg et 
















Figure 2.02 Global phylogeny of M. tuberculosis based on multi-locus sequencing 
of 89 genes from 108 strains. (Taken directly from Hershberg et al., 2008). 
 
2.3 The Global Phylogeny of M. tuberculosis  
 
Early studies using single nucleotide polymorphism analysis, based on the 
sequence analysis of 26 structural genes of MTBC, revealed two non-synonymous 
single nucleotide polymorphisms (nsSNP) at katG codon 463 (the gene encoding 
catalase peroxidase) and gyrA codon 95 (the gene encoding the A subunit of DNA 
gyrase). Based on these polymorphisms, M. tuberculosis was classified into three 
principal genetic groups (PGG) as described in Figure 2.03109. 
Figure 1. Maximum Parsimony Phylogeny of M. tuberculosis Complex Using 89 Concatenated Gene Sequences in 108 Strains
The branches are colored according to the main lineages defined previously based on our genomic deletion analysis, except for the animal-adapted
strains, which are indicated in orange. The main clades are labeled according to their dominance in particular geographic areas. The branch leading to
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Figure 2.03 The classification of MTBC into principal genetic groups based on two 
non synonymous Single Nucleotide Polymorphisms. (Taken directly from 
Sreevatsan et al., 1997).  
 
 
Later studies used LSP analysis to construct phylogenetic classification schemes. 
Brosch et al. proposed a new MTBC phylogenetic classification based on analysis of 
20 variable genetic markers in 100 strains of MTBC. The majority of these 
polymorphisms resulted from irreversible genetic events in ancient progenitor 
mycobacterial strains. The authors divided M. tuberculosis into “Modern” and 
“Ancestral” strains based on the M. tuberculosis specific deletion 1 (TbD1). The 
genetic deletion RD9 defines an evolutionary lineage represented by 
Mycobacterium africanum, Mycobacterium microti and Mycobacterium bovis that 
diverged from the progenitor of present M. tuberculosis strains before TbD1 
occurred. Since RD9 is not present in Mycobacterium canetti strains, these strains 
are considered to be direct descendants of tubercle bacilli that existed before the 

















Figure 2.04 The evolution of M. tuberculosis complex as determined by region of 
deletion region of deletion analysis. (Taken directly from Brosch et al., 2002).  
 
 
Baker et al. utilized multi-locus sequence typing (MLST) of seven housekeeping 
genes, which are associated with antimicrobial drug resistance in 225 clinical 
isolates from hospitals in England and Wales. The study identified 36 sSNPs that 
were geographically associated with the patients’ country of origin and classified 
M. tuberculosis strai s into four distinct lineages. However, the numbers of genes 
selected in this study were limited and so unable to resolve a more detailed 
phylogeny of M. tuberculosis167. 
Subsequently, Brudey et al. constructed a large spoligotype database (SpolDB4) 
including a broad global collection of M. tuberculosis spoligotype patterns and 
classified them according to spoligotyping families160. This phylogeny broadly 















Gagneux et al. classified M. tuberculosis into six major lineages, based on LSP 
analysis of 875 MTBC strains from 80 countries (Figure 2.01). Certain lineages 
were predominant in specific geographic areas and named according to the 
geographical distribution: the East Asian lineage (commonly known as the W-
Beijing strain family), East-African-Indian lineage, Euro-American lineage, Indo-
Oceanic lineage, and West African 1 and West African 2 lineages111.  
Although LSP based approaches of defining tuberculosis phylogeny are broadly 
effective in classifying M. tuberculosis strains, the genetic distances between the 
lineages are not clear and mycobacterial evolution pattern might not be completely 
imitated by such classification110.  
In an important recent study, Hershberg et al. performed multi-locus sequence 
analysis of 89 complete genes in 108 strains, which includes 1.5% of the total 
genome from each strain. The study identified a total of 488 SNPs and established 
a phylogenetic correlation between genetic variability in M. tuberculosis strains 
and the geographical distance travelled by these strains from the ancestral 
progenitor112. The phylogenetic tree produced by this study was concurrent with 
the LSP-based phylogenetic analysis (Figure 2.02)111. Further, the authors 
identified three ancient strain lineages in the African zone including the 
Philippines and the Rim of the Indian Ocean, suggesting an origin for the MTBC in 
Africa and subsequent spread throughout the world following human migration 
patterns112. This hypothesis also supported the anthropological evidence that 
modern humans spread out from Africa168. Additionally, this phylogenetic analysis 
divided modern M. tuberculosis strains into three modern lineages (Euro-
American, East African Indian and East Asian). Furthermore, these modern strains 















respectively and spread worldwide due to more recent migration and proliferation 
of the human population. The route of the modern strain transfer was 
hypothesized to have been via water transportation due to the contemporary use 
of ships during this period112. The presence of the ‘red strains’ (Euro-American) in 
Asia, Africa and in the Middle East indicated the spread of these strains due to 
European colonization. Further, the spread of the ‘blue strains’ (East-
Asian/Beijing) in South Africa may have been related to human migration from 
South-East Asia to South Africa due to slavery in the gold mines during Dutch 
colonization. Additionally, the presence of the ‘purple strains’ (East-African-Indian 
strains) in East-Africa was supported by the history of migration of human 
populations to East-Africa from the Indian subcontinent. This study also 
highlighted a molecular evolutionary approach to detect fitness in M. tuberculosis 
complex. It was found that purifying selection against potentially deleterious 
mutations was highly reduced in MTBC compared with other bacteria resulting 
into a high ratio of non-synonymous to synonymous SNPs (DN/DS).  The authors 
suggested that increase in non-synonymous mutation might associate with 
random increase in the genetic drift, which in turn was influenced by the human 
demography, migration of human populations and patient-to-patient 
transmission112.  
Comas et al. performed whole genome DNA sequencing of 22 strains 
representative of the six global phylogenetic lineages. Comparative sequence 
analysis of these strains provided 9037 unique SNPs from single or multiple 
strains169. The classification system derived from this analysis was highly 
congruent with the LSP and SNP based classification system169. Based on this 















MTBC lineages: “Lineage 1 (also known as Indo-Oceanic lineage)”, "Lineage 2 (also 
known as East Asian; includes "Beijing")", "Lineage 3 (also known as CAS/Delhi)", 
"Lineage 4 (also known as Euro-American)", “Lineage 5 (also known as West 
African 1)” and “Lineage 6 (also known West African 2)”169. This nomenclature will 
be used from this point in this thesis, since it avoids confusion caused previously 
by the use of conflicting names for different lineages. 
A comparison in spoligotyping, LSP and genome-based classification is given in 
Table 2.1.  Note the confusion generated by the different use of the terms “East 
African Indian” lineage and EAI spoligotype family, which refer to completely 
different strain lineages. 
Table 2.01 Global phylogenetic classification of M. tuberculosis strain lineages 
based on large sequence polymorphisms (LSP) and spoligotyping. 
MTBC species Spoligotyping 
based families 
(Brudey et al., 
2006) 
LSP based lineages 
(Gagneux et al., 
2006) 
Genome-based phylogeny 
(Comas et al., 2010) 
M. tuberculosis EAI Indo Oceanic Lineage 1 
M. tuberculosis Beijing East –Asian Lineage 2 
M. tuberculosis CAS East-African Indian Lineage 3 
M. tuberculosis H, LAM, X, T, S 
others 
Euro-American Lineage 4 
M. africanum AFRI2 West African-I Lineage 5 
M. africanum AFRI1 West African-II Lineage 6 
EAI- East African Indian, CAS- Central Asian, H- Haarlem, LAM-Latin American Mediterranean, 
AFRI- M. africanum. 
2.4 Description of modern strain lineages of M. tuberculosis 
2.4.1 Lineage 2 (East – Asian, includes Beijing strains) 
 
Strains from the Beijing genotype (lineage 2) possess a characteristic spoligotyping 















43 in the direct repeat region121, 170. Beijing genotype strains (lineage 2) 
predominate in eastern Asia170, however these strains are ubiquitous and have 
been found to be transmitted globally171, 172. Evidence suggests these strains are 
emerging in many parts of the world. A study from major paediatric referral 
hospitals in Cape Town, South Africa identified a 20% increase in the proportion of 
W-Beijing strains between 2000 to 2003 amongst isolates of M. tuberculosis from 
children121. Furthermore, the study also found that these strains were absent in 
histological samples over the period of 1930-1965, rare in 1966-1995 (2.8% 
samples) and rapidly emerging during 1996-2005 (20% samples)121.  
Based on the presence of IS6110 in the NTF-1 region of the chromosome, Beijing 
strains have been divided into two sub-lineages. Firstly, modern or ‘typical’ Beijing 
strains possess an IS6110 insertion in the NTF region and are distributed 
worldwide. In addition, so-called ‘W’ strains possess a mutation in the mut gene, 
which encodes a DNA repair enzyme121, 171, 173-176. These ‘W-Beijing’ strains are 
responsible for worldwide outbreaks, are major causes of tuberculosis in China, 
Russia and South Africa and are associated with multidrug resistant tuberculosis 
infection170-172. Secondly, ancient or ‘atypical’ Beijing strains (these are still 
included amongst modern strain lineages of M. tuberculosis) do not possess an 
insertion in the NTF region and are less widely distributed, but are found 
frequently in Japan and Korea173, 177-179.  
In a recent study from Japan, modern Beijing strains were shown to transmit more 
frequently amongst the younger generation than ancient Beijing strains176. The 















Beijing lineage is not clear. The modern Beijing lineage might be better adapted to 
spread in modern human societies119, 171, 172. However, despite the global spread of 
modern Beijing strains, an ancient Beijing strain caused a serious outbreak 
amongst the homeless population in the United States180. Furthermore, ancient 
Beijing strains with low-fitness cost rifampicin resistance mutations have been 
identified as a cause of tuberculosis amongst HIV-infected patients in the Eastern 
Cape province of South Africa181.  
Other classification schemes have been proposed for W-Beijing strains, including a 
scheme based on LSP analysis which divides the Beijing lineage (Lineage 2) into 
five subgroups165.  
2.4.2 Lineage 3 (CAS/ Delhi) 
 
Lineage 3 (CAS) strains are largely distributed in the Indian subcontinent, the 
Middle East, and Central Asia and comprise approximately 30% of circulating 
strains in these regions160. This lineage is also common in East Africa, which has 
experienced substantial Indian migration120, 160 and amongst the Indian population 
in the United Kingdom182. The Lineage 3 is designated as the Central Asian strain 
(CAS) family in the spoligotype database and has a particular spoligotype signature 
that involves deletion in spacers 4 to 27 and 23 to 24. This lineage is related to 
lineage 2 strains (Beijing) and shows a close relationship with Beijing strains on 
spoligotyping and MIRU-VNTR183.  
2.4.3 Lineage 4 (Euro-American) 
 
Lineage 4 (Euro-American strains) predominates in Europe, America, the Middle 















group 2 and 3 as described by Srevatsan et al.109 and consists of a wide range of 
spoligotype families including Latin American Mediterranean (LAM), Haarlem, X 
and T families of strains160. Based on spoligotype data, Brudey et al. proposed 
various subgroups within the Latin American Mediterranean family - LAM1 to 
LAM12160. Haarlem strains are distributed worldwide, including in Europe160 and 
the Caribbean184. Low IS6110 copy number-containing ‘X’ family strains are 
common in the United Kingdom and in North America185. In Africa, LAM, Haarlem, 
and T family strains are common186. LAM3 strains are common in South Africa187, 
188. 
2.5 Virulence of M. tuberculosis  
 
Virulence can be defined as the ability of a pathogen to cause severe disease in the 
human host189. It is not possible to define virulence in M. tuberculosis simply in 
terms of specific virulence determinants as it does not have clearly defined 
virulence factors such as exotoxin production by Clostridium tetani190 or 
Staphylococcus aureus191. Host and bacterial factors both play an important role in 
the outcome of infection with M. tuberculosis. For example the level of serum 
vitamin D is considered to be a risk factor in M. tuberculosis infection; individuals 
with low level vitamin D levels have shown increased risk of developing detectable 
tuberculosis infection50. Age192 and host immune status play critical roles. As an 
example of the interplay of host and strain factors, the relatively less virulent M. 
africanum strains cause tuberculosis disease in HIV-infected patients in West 
Africa, but less commonly in HIV-uninfected individuals193, 194. Differences in the 
outcome of infection by different strains may be mediated by strain-specific 
immune responses. For example, the outbreak strain, CDC1551 (a lineage 4 strain),  















Kentucky region in United States but few cases of active tuberculosis disease, 
suggesting high immunogenicity, but low virulence140.  
Early comparative studies of virulence were limited by the lack of genotyping 
information, which made it difficult to assign particular virulence characteristics to 
specific strains or strain families. Recently, there has been substantial work to 
assess the relation between M. tuberculosis genotype and virulence in human cell 
cultures and animal infection models. However, findings are not always consistent, 
due to variation in the specifics of the model used, the selection of strains and, 
probably operator-dependent issues.  
2.5.1 The human macrophage model of M. tuberculosis virulence 
 
Tissue culture models are less time consuming and resource intensive than animal 
models. However, a tissue culture model can only partially represent the very early 
stages of tuberculosis infection while animal models may also be useful to 
understand later stages of infection. M. tuberculosis invades alveolar macrophages, 
which are the primary site of intracellular replication and persistence. Early 
control of replication by macrophages is likely to play an important role in 
determining the outcome of infection. Since M. tuberculosis is an intracellular 
pathogen which has adopted various strategies to adapt to the host’s cellular 
environment, it is useful to consider the host-pathogen relationship at the cellular 
level as a virulence characteristic. M. tuberculosis utilizes different strategies to 
survive and replicate in the intracellular environment. Following ingestion by 
macrophages, M. tuberculosis is channelled to the phagosome195. Following 
phagocytosis, phagosomes fuse with lysosomes, which results in degradation of 















antimycobacterial activity of macrophages by arresting fusion of phagosomes with 
lysosomes196. M. tuberculosis also modulates H+ ion concentration in the 
phagolysosome by inhibiting fusion of infected vacuoles with the proton pump-
ATPase, responsible for creating an acidic environment within the phagolysosome, 
resulting in reduced acidity inside the phagolysosome and functional failure of 
lysosomal acid hydrolases197. Furthermore, the phagosomal pathway interacts 
with the endocytic pathway involving the Ras family GTPase. Experimental 
evidence in mycobacterial infection shows the presence of the early endosome 
marker Rab-5 instead of the late endosome marker Rab-7 on mycobacterial 
phagosomes, indicating phagosomal arrest during M. tuberculosis infection198. 
Additionally, the tryptophan aspartate containing coat protein (TACO), which is 
normally associated with cholesterol in the plasma membrane199, is recruited 
during early phagosome formation and is essential for phagosomal maturation. 
However, mycobacteria are able to retain this protein in phagosomes, thus 
inhibiting its supply to lysosomes, resulting in inhibition of phagosomal 
maturation during M. tuberculosis infection200. Since the ability of M. tuberculosis to 
survive and replicate in the host macrophage is key to the development of disease, 
the ability of strains of M. tuberculosis to survive and grow in the macrophage or 
monocyte model may be a useful surrogate marker of virulence. Various human 
monocyte cell lines such as THP1 (the acute monocytic leukaemia cell line) have 
also been used in ex vivo tuberculosis models to measure intracellular growth and 
cytokine induction134, 201. While monocytic cell lines are similar in many respects to 
primary human macrophages, they are produced from transformed cells from a 















e.g., THP1 cells possess Fc and C3b receptors on the cell surface but lack surface 
and cytoplasmic immunoglobulins202. 
All models of infection have limitations in their ability to replicate human disease, 
however they may offer useful insights that can be validated in studies of humans 
with tuberculosis.  
2.5.2. Intracellular growth within monocytes/macrophages as a virulence 
characteristic 
 
Lineage 2 strains (Beijing) have been the most extensively studied clinical strains. 
In vitro studies demonstrated that individual strains from lineage 2 grew rapidly in 
human cell culture models using monocyte derived macrophages (MDM) or 
monocytes or human macrophage cell lines132, 203.  Zhang et al. utilized a MDM 
model to study the correlation between the extent of the spread of M. tuberculosis 
strains in a Los Angeles community setting and the ability of the strains to grow in 
human macrophages132. In this study, a lineage 2 strain 210 responsible for 25% of 
tuberculosis cases in Los Angeles, grew more rapidly in human MDM than strains 
which caused disease in single patients who came in contact with many persons in 
a homeless shelter132. Li et al. found significant differences in the growth of 
different M. tuberculosis strains in human monocytes and found that four lineage 2 
strains grew more rapidly than Erdman, CDC1551 and several other non-Beijing 
strains203. Subsequently, Theus et al. also demonstrated that the growth of lineage 
2 strain 210 was significantly faster than that of unique strains in activated THP1 
monocytic cells134. Theus et al. further demonstrated that strains that clustered 
using RFLP analysis grew more rapidly than unique RFLP pattern strains. This was 















strains, which was hypothesized to decrease the production of tumour necrosis 
factor (TNF) during early stages of infection204.  
   Taken together, the above experimental evidences suggest that lineage 2 strains 
(Beijing) replicate more rapidly in human macrophages than other strain lineages, 
indicating a possible virulence-associated characteristic for this lineage. However, 
there are contradictory studies, which suggest that rapid growth in macrophages is 
not a common characteristic of all lineage 2 strains. In a further study, Theus et al. 
performed intracellular growth assays in a THP1 cell line using various lineage 2 
strains to assess whether rapid growth was characteristic for a broad range of 
lineage 2 strains. The authors found that three lineage 2 strains grew more slowly 
than the others whilst strain 210 grew faster, suggesting variation in the 
intracellular growth rate amongst lineage 2 strains205.  
   Intracellular growth of M. tuberculosis in macrophages is partly controlled by 
cellular apoptosis since programmed cell death kills bacteria and enhances 
containment of the bacterial infection. A recent study from Korea has reported that 
K strain, a frequently found virulent lineage 2 strain in Korea, causes less cellular 
apoptosis and induces more necrosis in human monocytic THP1 cell lines than 
H37Rv. K strain causes more up regulation of the anti-apoptic Bcl-2 family gene 
than H37Rv and slight up regulation of anti-apoptic Bax gene similarly as H37Rv in 
the THP1 cell line206.  
    Intracellular growth of strains from other lineages has also been examined, but 
data are more limited. A recent study from Pakistan demonstrated that a lineage 3 
strain (CAS1) with deletion in RD149 grew slowly in THP1 cells when compared 
with a lineage 3 strain without the corresponding deletion or H37Rv and lineage 3 















American) have been frequently studied, probably as this lineage predominates in 
Europe and the United States. Li et al. demonstrated that the outbreak strain 
CDC1551 (lineage 4- X family strain), which was responsible for a high degree of 
skin test conversion amongst contacts in the South-Eastern USA (and reportedly 
grew faster than the Erdman strain but slower than H37Rv in mice), grew more 
slowly than the Erdman strain in human monocytes203. Haarlem strains (lineage 4, 
Euro-American), which have been found to grow faster in activated murine 
macrophages than H37Rv207 and cause extensive outbreaks of multidrug resistant 
tuberculosis in Argentina183, were shown to be characterized by six LSPs which 
disrupted physiologically important genes such as Rv1354c and cyp121. 
Interestingly, both of these genes are considered a drug target for M. tuberculosis. 
Rv1354 encodes cyclic- di-GMP, a messenger molecule involved with the bacterial 
inner membrane208. The cytochrome 450 cyp121 gene in M. tuberculosis H37Rv 
was found to be involved in bacterial electron transport system, producing an 
enzyme that serves as an active site for binding to anti-mycobaterial (azole) 
drugs209. In an another report, strain-5 (lineage 4), a prevalent mycobacterial 
isolate in Madrid, where it was associated with HIV-infection and prison 
outbreaks, showed more rapid growth in THP1 cells during the first 24 hours of 















2.5.3 Animal models of M. tuberculosis virulence 
Virulence can be assessed more directly in animal models of disease. Although 
animal models have limitations211, various animal studies have used mice, guinea 
pigs, rabbits, and primates to identify virulence characteristics and compare 
virulence between strains of M. tuberculosis. Virulence has been most commonly 
assessed in the mouse model by measuring bacterial burden, histopathological 
evidence of inflammation and tissue destruction and the induction of delayed type 
hypersensitivity (DTH)129, 212.Further, rabbit models have been extensively used in 
tuberculosis research because they show disease similar to humans, characterized 
by typical granuloma formation with caseation, liquefaction, and cavitation213, 214. 
Recently, non-human primates have been used to study tuberculosis, with close 
replication of a broad range of tuberculosis dise se manifestations from latency to 
fulminant tuberculosis215. 
2.5.4 Growth of M. tuberculosis strains in animal models as a virulence 
characteristic 
 
   The virulence of M. tuberculosis strains has been assessed in various animal 
infection models by measuring the extent of bacillary replication in different 
primary target organs (such as lung and spleen), the extent of end organ damage 
(measured using histopathological score, organ weight) and lethality. Lopez et al. 
demonstrated that Beijing strains (lineage 2) produce extensive pneumonia and 
early death in mice as compared to M. canetti and Haarlem (lineage 4) strains of 
tuberculosis135. In an attempt to compare the virulence of multiple different strains 
of M. tuberculosis, Dormans et al. determined the virulence of 19 strains in BALB/c 















hypersensitivity. The study reported that Beijing genotype strains 2 & 3 (lineage 2)  
were hypervirulent,  as were Somali (lineage 3) and Haarlem (lineage 4) strains as 
manifested by early death and increased bacillary burden when compared with 
H37Rv, M. canneti and Beijing strain 1 (lineage 2). This suggests that lineage 2 
strains may differ in virulence129. These data suggest that lineage 2 strains differ 
with respect to virulence and that virulence correlates with the transmissibility of 
the lineage 2 strains130. Further, Agruiler et al. selected lineage 2 strains from 
different sub lineages (according to a classification scheme by Hanekom et al., 
2007175) based on transmission criteria in series of tuberculosis cases in patients. 
The transmissibility of lineage 2 strains was categorized in mice by co-housing the 
mice with or without infection with different strains from lineage 2 subgroups130. 
The author reported that mice infected with highly transmissible lineage 2 strains 
died earlier (within 5 weeks post-infection) with a higher histopathological score 
than did mice infected with non-transmissible lineage 2 strains (died within 4 
months post-infection). The mice infected with highly virulent Beijing strains 
produced low level of IFN-, ephemeral TNF and high levels of IL-4 (in the later 
stages of infection) than those infected with low virulence Beijing strains. 
2.5.5 Induction of innate immune responses by M. tuberculosis strains as a 
virulence characteristic 
 
There is evidence of variation in the induction of immune responses by different M. 
tuberculosis strains132, 136, 138, 204, 206, 216-219. Individual strains differ in their ability 
to induce cytokine production in various in vitro and in vivo models of infection. 















explanations for this variation could be the use of slightly different experimental 
models and the lack of standardization in strain selection. 
Lineage 2 strains  have been most widely studied. The propensity of lineage 2 
strains to induce low levels of pro-inflammatory cytokines (TNF, IL-6, and 
IL12p40) relative to comparator strains is consistently reported in various in vitro 
studies. For instance, a study from Korea found that a lineage 2 strain, K strain, 
induces lower levels of protective cytokines such as TNFα, IL-6, and IL12p40 than 
H37Rv in a human monocytic THP1 cell line206. This finding was further supported 
by recent studies by Tanveer et al. who demonstrated that lineage 2 strains, along 
with lineage 3 strains (CAS ),  induce low levels of pro-inflammatory cytokines 
such as TNF and IFN- in THP1 cells and in whole blood assays219. Subsequently, 
Wang et al. studied various sublineages of the  lineage 2 strains  and demonstrated 
consistently low cytokine induction in  in vitro models216. The authors describe  
low levels of IL-6, TNF, IL-10 and GRO-α production by a range of lineage 2 strains 
from different sublineages in human macrophages and dendritic cells as compared 
to H37Rv216. A recently reported human clinical study from Madagascar found that 
PBMCs infected with modern group-1 strains [including CAS (lineage 3) and 
Beijing strains (lineage 2), according to a classification scheme by Arnold et al.220] 
induce lower levels of antigen-specific IFN- than the modern group-2 [Harlem, 
LAM and X strains (lineage 4)] and ancient strains (lineage 1, Indo-Oceanic 
lineage), suggesting that these strains might have evolved mechanisms to subvert 
the Th1 response that may provide a selective advantage to these lineages218. 
Similarly, Portevin et al. found that modern strain lineages (Lineage  2,3 & 4) 
induce low levels of inflammatory cytokines, such as TNF, IL-6, IL-12p40, IFN-, as 















and monocyte derived dendritic cells217. Of interest, before the development of 
genotyping techniques, very early studies reported that southern Indian strains 
were less virulent than strains from the United Kingdom in guinea pig models221. 
The predominant strain lineage in Southern India is Lineage 1 (Indo-Oceanic, an 
ancient strain lineage) whilst lineage 4 strains (Euro-American, a modern strain 
lineage) predominate in the United Kingdom111.  
The specific mechanism by which containment of intracellular growth occurs in M. 
tuberculosis infection is unknown. In murine studies, containment depends, in part, 
on reactive oxygen intermediates and nitric oxide, whereas in humans the role of 
these molecules remains unclear. BALB/c mice produce high levels of Th1 cell 
cytokines and inducible nitric oxide synthase (iNOS) in the early stages of 
infection, which facilitate containment222, 223. Lopez et al. showed that BALB/c mice 
demonstrated transient increases in TNF and iNOS mRNA and a low level of IFN- 
expression following infection with Beijing strains (lineage 2), whilst infection 
with M. canetti resulted in high and sustained TNF- α and iNOS mRNA 
expression135.   
Manca et al. studied levels of cytokine induction in B6D2F mice after infection with 
outbreak strains of M. tuberculosis224. The lineage 4-outbreak strain (Euro-
American), CDC1551, induced high levels of TNF- α, IFN-, IL-12, IL-10, and IL-6 
mRNA in the lungs of mice133. Conversely, the lineage 2 outbreak strain (Beijing), 
HN878, (which caused early death of mice) induced lower levels of TNF- α, IL-6, IL-
12 and IFN- mRNA in lungs, while IL-10, IL-4 and IL-5 mRNA levels were 
significantly increased, suggesting a shift from Th1 to Th2 cytokine induction. The 
hypervirulent characteristic of HN878 was associated with an increase in 















purified IFN/ resulted in an increase in the bacillary load in lungs 28 days post-
infection and was associated with a reduction in IL-12 mRNA in lungs and 
decreased survival225. 
Subsequently, Manca et al. further demonstrated that HN878 as well as lipid 
extracts from this strain induced low levels of IL-12 (a Th1 cytokine) and increased 
Th2 cytokines such as IL-4 and IL-13. In contrast, the lineage 4 strain  CDC1551 
induced more Th1 cytokines such as IL-12 and TNF136. Therefore, the outcome of 
tuberculosis infection may relate, in part, to the balance between Th1/Th2 
cytokines226. The immune suppressive phenotype of HN878 is associated with the 
presence of biologically active phenolic glycolipid (PGL-tb) in the cell wall of this 
strain136. PGL-tb has been identified in many lineage 2 strains (Beijing subgroups 
3, 4, 5, according to a subgrouping of the Beijing lineage as described by Gagneux 
et al. 2006111) having an intact pks1-15 gene (polyketide synthase). This enzyme is 
involved in synthesis of PGL-tb139. PGL-tb is associated with suppression of pro-
inflammatory Th1 cytokines such as TNF, IL-6 and IL-12 and has been associated 
with virulence in the mouse model136, 139, 224.  However, PGL-tb is also present in 
other M. tuberculosis strains such as M. canetti227. Most other strain lineages have a 
7bp deletion in pks1-15, which causes a frameshift mutation and makes them 
incapable of synthesizing PGL-tb227. In order to determine the impact of PGL-tb on 
bacterial virulence and the immune response, Sinsimer et al. constructed PGL-
producing recombinant H37Rv by transforming the pks1-15 gene into H37Rv. The 
transformed H37Rv propagated at the same rate as the wild-type strain in human 
monocytes, suggesting that PGL-tb does not affect in vitro growth in monocytes. 
Further, based on bacterial colony count on lungs, spleen, and survival, 















rabbits than wild type H37Rv228.  However, several cytokines (IL-1, TNF, IL-10 
and IL-17) levels were lower in the PGL-transformed H37Rv mutant than the wild 
type H37Rv strain in human monocytes228. However, PGL-tb is not the sole 
mediator of the immune-suppressive phenotype of Beijing strains (lineage 2). Low 
levels of pro-inflammatory cytokines have been shown to be induced by both PGL-
tb positive (W4) and PGL-tb negative (N4) Beijing strains228, suggesting that PGL 
may work together with other lipid or protein factors which could also be virulent 
determinants in lineage 2 strains228. As PGL-tb is absent in most M. tuberculosis 
clinical strains, this lipid molecule is clearly not a fundamental virulence 
determinant, but it may impart a ‘hypervirulent’ characteristic to strains with 
certain genetic backgrounds228.  
It has been suggested that alternative molecular mechanisms are likely to be 
involved in the success of lineage 2 strains. As such an alternative, Reed et al. 
demonstrated that the lineage 2 strains constitutively overexpressed genes of the 
DosR regulon (including dosR, Rv3130c, hspx, fdxA and narX) in normal in vitro 
growth condition, while other lineages only showed induction of the regulon 
following exposure to hypoxia or nitric oxide139. Domenech et al. further 
demonstrated that the modern group of Beijing strains possess a duplicate copy of 
the dosR gene, which might be partly responsible for overexpression of DosR229. 
Lineage 2 strains produce large numbers of triacylglycerides in in vitro aerobic 
cultures, which interestingly, coincides with the up-regulation of the gene 
Rv3130c139. This gene is responsible for production of the enzyme triacylglyceride 
synthase and is a member of the M. tuberculosis DosR regulon. Thus, lineage 2 
strains are capable of synthesizing fatty acids such as triacylglycerides, which are 















during infection139. Hence, activation of the DosR regulon is thought to confer an 
adaptive advantage to M. tuberculosis to facilitate survival within hypoxic 
conditions in granulomas139.  
Much attention has focused on lineage 2 strains, however outbreak strains from 
other families have also been associated with immune subversion. The lineage 3 
(CAS) strain, CH, caused a tuberculosis outbreak amongst school children in 
Leicester, in the United Kingdom. CH was reported as a cause of 254 cases of latent 
tuberculosis infection and 77 cases of active pulmonary tuberculosis within a 
year140. CH-infected MDMs induced less protective IL12p40 and more anti-
inflammatory IL-10 than H37Rv. CH also induced up-regulation of IL-10 mRNA 
expression in MDMs138. This immune phenotype was ascribed, in part, to a deletion 
in Rv1519. The Rv1519 deletion is common to lineage 3 strains, and so the 
immune-subversive phenotype may represent a lineage-specific (rather than 
strain-specific) characteristic, although this has not yet been demonstrated.  
This evidence may suggest that the success of certain strain lineages of M. 
tuberculosis may be dependent upon their ability to subvert the normal host 



































The in vitro growth phenotype of M. tuberculosis 


























3.1   Introduction 
 
Variability in the outcome of infection with M. tuberculosis, such as latent230 and 
active tuberculosis231, treatment failure232 and emergence of drug resistance233 has 
highlighted the potential role of strain variation in influencing these outcomes. 
Assessment of virulence or fitness of different strains of M. tuberculosis is 
complicated by the lack of suitable animal models and the complexity and 
prolonged nature of human disease.   
The simplest measure of bacterial fitness is rate of growth, as determined by 
enumeration of bacterial growth by counting of acid-fast bacilli (AFB), by 
enumerating colony-forming units (CFU) or by estimating the turbidity of liquid 
bacterial culture234. These measures may give differing results as progression of 
bacterial growth may lead to the accumulation of death bacilli, which may add to 
total count (AFB) but not to the actual viable count (CFU) of bacteria. Furthermore, 
evidence suggests that bacilli in human tissues with latent infection may lose their 
acid fast characteristics235. Hence, viable bacterial count by CFU estimation is 
considered as more reliable method for enumerating mycobacterial growth 
kinetics in various models of host pathogen interaction. In the experiments below, 
we compared growth of different strains in axenic media by CFU estimation. 
Cell culture models have been widely used to assess various aspect of host 
pathogen interaction in tuberculosis including immunological responses and 
intracellular growth132, 134, 203, 236, 237. In this study, we used primary monocyte 
derived macrophages (MDM) from peripheral blood mononuclear cells (PBMC) 
from human subjects as an in vitro model. The monocyte-derived macrophage 















Tuberculosis in the Western Cape Province of South Africa is predominately 
caused by strains from two globally successful lineages - lineage 4 and lineage 2188. 
Lineage 2 strains have been found to be transmitted globally with a high tendency 
to cause outbreaks and multidrug-resistant tuberculosis infection, suggesting a 
better adaptation of this phylogenetic lineage to causing disease in the current 
epidemiological context172, 238. Strains from this particular genotype have been 
shown to replicate more rapidly in the human cell culture model132, 203, 204. Lineage 
4 (Euro- American lineage, including LAM, X and Harlem subfamilies of strains) is a 
highly successful lineage in Europe, America, and parts of Africa and the Middle 
East111, 188, 239, 240. The lineage 4 strain CDC1551 grew at a similar rate to H37Rv in 
human monocytes 133, 241. Further, lineage 3 (CAS, uncommonly seen in the 
Western Cape) strains predominate on the Indian sub-continent242-244 and have 
been shown to exhibit slower growth than H37Rv in axenic liquid media but 
similar growth in a cell culture model138, 201, 237. 
Various mouse studies have reported that recombinant IFN- pre-treated murine 
macrophages are able to induce anti-mycobacterial activity by a nitric oxide (NO)- 
mediated pathway. The catalytic oxidation of arginine to citrulline is mediated by 
iNOS (inducible nitric oxide synthase) that generates NO as a by-product. NO has 
potent bactericidal effect245.  In contrast, the role of NO mediated containment of 
mycobacterial growth remains unclear in humans with low levels of measurable 
NO following M. tuberculosis infection245, 246. We therefore compared the effect of 

















3.2 Aims of the study 
 
 To compare the rate of growth of modern strains of M. tuberculosis in axenic 
media in order to identify lineage-specific patterns of growth 
 To compare the rate of growth of modern strains of M. tuberculosis in 
primary human monocyte-derived macrophages in order to identify 
lineage-specific patterns of growth 
 To determine the growth modulatory effect of IFN- on different M. 
tuberculosis strains in primary human monocyte derived macrophages 
3.3 Methods 
 
3.3.1 Selection of M. tuberculosis strains 
 
We selected strains of M. tuberculosis from a previously described collection of 
paediatric isolates from the broader Cape Town region of South Africa188. Strains 
from children with tuberculosis are likely to be representative of circulating M. 
tuberculosis strains in the region, as childhood tuberculosis classically follows 
exposure to an infectious adult source case. It should be noted that these strains 
could have been conditioned differentially in their respective hosts when 
compared to strains derived from adults. Isolates were initially cultivated using 
BACTEC MGIT960 automated liquid culture and grown further in 7H9 
Middlebrook Medium prior to genotyping and in vitro cell culture assays. Overall, 
these strains were passaged approximately five times during the study period.   
We performed spoligotyping, 15-locus multiple interspersed repetitive unit-
variable number tandem repeat (MIRU-VNTR) analysis as well as region of 















strain lineages and strain clusters (Table 3.01). For these studies, all strains 
selected were from ‘modern’ lineages of M. tuberculosis, as representative strains 
from ‘ancient’ lineages were not available (Figure 3.01). We selected strains from 
each of the most common lineages in this strain collection, including three lineage 
2 strains (Beijing, including two RD150/RD181 and one RD181 deleted strain) and 
three lineage 4 strains (Euro-American, belonging to the LAM3/F11 subfamily). In 
addition, we selected two lineage 3 (CAS) strains (the previously described CH 



















Figure 3.01 Phylogenetic relationships of selected M. tuberculosis strains in radial 
trees based on 15 loci MIRU-VNTR and spoligotyping.
Lineage 4 (Euro-American) 
Lineage 3 (CAS) 
Lineage 2 (East-Asian) 
Modern lineages 
Ancient lineages 
.... , .. 




















  3.3.2 Preparation of mycobacterial culture 
  3.3.2.1 Culturing of M. tuberculosis strains 
 
To ensure a synchronous growth phase amongst all strains, M. tuberculosis 
strains were grown at 370C in a shaking incubator (120 rpm) to mid log phase 
(0.6 to 0.9 OD) in Middlebrook 7H9 broth (Difco, USA) containing 0.2% glycerol, 
0.05% Tween 80, and 10% albumin-dextrose-catalase (ADC) growth enrichment 
(BD, USA). Stock vials of M. tuberculosis culture from different strains were 
supplemented with 15% glycerol and preserved in multiple aliquots at -800C for 
growth assays. All experimental procedures with viable tuberculosis strains were 
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3.3.2.2 Standard stock culture preparation 
 
The total standard colony forming unit (CFU) concentration of the stock vial was 
calculated by serial dilution and plating in multiple replicate on Middlebrook 7H11 
agar (Difco, USA) containing 0.5% glycerol and 10% Oleic acid-albumin-dextrose-
catalase (OADC) growth enrichment (BD, USA). A new vial was thawed before each 
experimental procedure. The colony forming unit (CFU) content of an aliquot of 
each stock was re-confirmed during each experiment by plating on Middlebrook 
7H11 agar.  
3.3.3 Axenic growth assay  
3.3.3.1 M. tuberculosis growth in liquid 7H9 broth 
 
For axenic growth assays, frozen stock of known CFU concentration were freshly 
thawed and multiple replicates of 105 CFU/ml of bacilli of M. tuberculosis were 
inoculated into 10 ml pre-warmed 7H9 Middlebrook broth supplemented with 
0.2% of glycerol, 0.05% Tween 80, and 10% ADC growth enrichment (BD, USA) 
and cultured in a shaking incubator (120rpm) at 370C for 360 h. 
3.3.3.2 Quantification of M. tuberculosis growth in axenic culture 
 
Increase in bacterial number in liquid broth was evaluated at different time 
intervals. Aliquots were withdrawn at intervals and diluted up to six fold in 
Phosphate Buffered Saline (PBS). Bacterial clumping was minimized by thorough 
repetitive pipetting of diluted samples. Serial dilutions were plated in triplicate 
onto Middlebrook 7H11 agar plates containing 10% OADC growth enrichment and 
incubated at 370C. Colonies on plates were enumerated after 3 weeks of incubation 
















3.3.4 Intracellular growth assay 
3.3.4.1 Ethical considerations 
 
The study was conducted with ethical approval from the Faculty of Health Sciences 
Research Ethics Committee, University of Cape Town (REC REF 261/2008). The 
healthy donors buffy coats were collected from South African Blood Transfusion 
Services. 
3.3.4.2 Monocyte isolation, culture, and maturation to monocyte derived 
macrophages (MDM) 
 
MDM were prepared from healthy donor buffy coats supplied by South African 
Blood Transfusion Services. Peripheral blood mononuclear cells (PBMC) were 
separated by centrifugation over Ficol-paque Plus (Pharmacia, Uppsala, Sweden). 
Cells were washed in RPMI, pooled, and counted. Cells were incubated in a large 
tissue culture flask (175 cm2) at 300 X 106 PBMC per 25 ml RPMI per flask for 2 h 
at 370C in 5% CO2. This step allows monocytes to adhere to the bottom of the flask. 
Non-adherent cells were removed by three washes with 10 ml of pre-warmed 
RPMI medium. Finally, 10 ml of ice-cold phosphate buffered saline (PBS) was 
added and the flask incubated at 400C for 20 minutes. Using a long handled 
scraper, monocytes were dislodged from the bottom of the flask and pooled in a 50 
ml falcon tube for counting. Cells were plated in R10 medium (RPMI containing 
10% foetal calf serum (FCS)) at a concentration of 2x105 cells/well in a 96 well 

















3.3.4.3 MDM infection with M. tuberculosis strains and intracellular growth 
assay 
 
For the intracellular growth assay, frozen M. tuberculosis stock were freshly 
thawed and reconstituted at room temperature at the time of infection. Before 
infection, each stock vial was plated for CFU enumeration to re-confirm the CFU 
content of the inoculum. Adherent MDM were co-cultured in duplicate with bacilli 
at a 1:1 ratio in R10 medium (RPMI+ non-heat inactivated 10% FCS). After 4 h of 
incubation, extracellular bacteria were removed gently by washing four times with 
pre-warmed PBS and replenished with fresh R10 medium. We confirmed removal 
of extracellular bacilli from the infected MDM by plating the washing buffer from 
the last wash onto 7H11 agar plates. 
3.3.4.4 CFU analysis from infected MDM lysates 
 
After 4, 24, 48 or 96 h of infection, MDM from each of the duplicate wells were 
subjected to complete lysis by mixing with 100 µl of 0.1% SDS and incubated at 
room temperature for 12min. Lysates were mixed thoroughly ten times, serially 
diluted (10-1 to 10-6), and plated, in triplicate, on 7H11 agar plates. Plates were 
incubated for 3 weeks at 370C and CFU enumerated using an inverted microscope. 
3.3.4.5 Intracellular growth assay in IFN- stimulated MDM  
 
Monocytes were isolated from buffy coats and matured into macrophages as 
described above. 24h prior to infection mature macrophages were pre-stimulated 
with R10 medium containing 100 U/ ml of recombinant human IFN- (BD 
Pharmingen). Each experiment was set up with an IFN- unstimulated control. 
Infection of macrophages was then performed as above. At the 4h time point, 
extracellular bacteria were removed by washing with pre-warmed PBS and each 















IFN-. Unstimulated control wells were replenished with fresh pre-warmed R10 
medium. After 4, 24, 48 and 96 h, infected MDM were lysed for CFU enumeration 
as described above. 
3.3.4.6 MTT assay 
 
The cytotoxicity of IFN- treatment of monocyte derived macrophages was 
determined by MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium 
bromide) assay. Cytotoxicity is measured by reduction of the yellow tetrazolium 
salt of MTT to purple formazan by mitochondrial enzymes of living cells. 2x105 
monocytes were plated onto 96-well flat bottom plate and cultured to form MDM 
using R10 medium for 6 days at 370 C and 5% CO2. Monocyte derived macrophages 
(MDM) were pre-treated with 100 U/ml of IFN- at 24h prior to MTT assay. The 
remaining IFN- treated wells were washed off after 24 h of incubation and the 
well replenished with fresh R10 media containing 100 U/ ml of IFN-.  A control 
well, not treated with IFN-, was set up for each test well. At 24h, 48h and 96h 
10μl of MTT (5mg/ml) was added into each well, followed by incubation at 37°C 
for 2 h. Purple formazan was solubilized in 0.04N HCl in isopropanol, incubated on 
a shaker for 30 min and absorbance read at 570nm. 
3.3.5 Statistical analysis 
 
Graphpad Prism 5.00 was used for statistical analysis of intracellular growth in 
monocyte-derived macrophages. The intracellular growth index in MDM infection 
was compared between different groups using the unpaired t test for each time 
point. One-way ANOVA was used to compare the growth in MDM to measure the 















comparison. Axenic growth curve analysis was performed with one-way ANOVA 
and Bonferroni’s post hoc test. 
3.4 Results 
3.4.1 M. tuberculosis growth in broth 
 
M. tuberculosis strains belonging to different M. tuberculosis lineages were grown 
in liquid 7H9 Middlebrook broth to compare the growth rate of different lineages 
(two independent cultures, each performed in triplicate) (Figure 3.02 & 3.03 A, B). 
We used Cmax and Tmax to compare growth of various strains. Cmax is defined as the 
peak point on the bacterial growth curve (maximum number of colony forming 
units) whilst Tmax is the time required to reach Cmax. H37Rv grew to a higher Cmax 
than clinical strains (Table 3.02). Lineage 4 strains showed a higher Cmax than 
clinical strains from other lineages. (Figure 3.03 C) Lineage 2 strains showed an 
intermediate level of growth whilst lineage 3 strains had the lowest Cmax [Cmax, 
H37Rv vs. lineage 4 /lineage 2 / lineage 3 all p<0.0001; lineage 4 vs. lineage 2 
p=0.0024; lineage 4 vs. lineage 3 p=0.0005]. Tmax for H37Rv was 288 h. Lineage 3 
strains showed significantly shorter Tmax than H37Rv (p<0.05) (Figure 3.03D). The 
replicates of dilutions gave very reproducible results; suggesting that minimal 
















Figure 3.02 Growth of M. tuberculosis strains in liquid broth. (A, B, C) H37Rv; 
Lineage 3 strains (purple): CH and RXH379; (D, E, F) Lineage 4 strains (Red): 
RXH202; RXH266; RXH6; (G, H, I) Lineage 2 strains (Blue): RXH248; RXH360; 

















Figure 3.03 Growth of M. tuberculosis strains in liquid 7H9 broth. (A) Growth 
of individual M. tuberculosis strains from different lineages in liquid 7H9 broth. 
Data represent the mean and range (n=2) values. (B) Summarized (mean) growth 
of M. tuberculosis strain lineages. (C) Comparison of Cmax (maximum point on the 
growth curve) for different strain lineages. Lineage 4 strains showed higher Cmax 
than lineage 2**(p=0.01) and lineage 3*** strains (p=0.001). H37Rv showed 
significantly higher Cmax than all clinical strains# (p=0.001) (D) Comparison of Tmax 
(time to reach to Cmax) for different strain lineages. H37Rv reached Tmax 





























Table 3.02 Strain wise comparison of M. tuberculosis growth in axenic media 
based on Cmax # and Tmax # # values.  
 
Strain Lineage Cmax (CFU / ml) Tmax (h) 
 H37Rv Laboratory strain 5.14 ± 0.68 x 108 288 
 RXH24 Lineage 2 4.50 ± 0.02 x 108 204 
RXH248 Lineage 2 5.33 ± 1.4 x 107 288 
RXH360 Lineage 2 9.07 ± 2.7 x 107 264  
 CH Lineage 3 1.69 ± 0.34 x 107 216 
RXH379 Lineage 3 3.68 ± 0.97 x 107 180  
RXH202 Lineage 4 1.44 ± 0.082 x 108 240 
RXH266 Lineage 4 1.46 ± 0.29 x 108 252  
 RXH6 Lineage 4 2.10 ±0.70 x 108 240 
    # Cmax: maximum number of colony forming units, # # Tmax: Time required to reach Cmax. Data 
represent mean ± SD obtained from two separate growth experiments.  
 
3.4.2 M. tuberculosis growth in monocyte derived macrophage  
 
We used the MDM infection model to evaluate differences in intracellular growth 
in MDM from different donors (n= 7). We determined initial strain uptake (after 4 
h) by expressing the number of CFU at the 4 h time point from MDM lysates as a 
percentage of the initial inoculum (Figure 3.04). H37Rv showed lower strain 
uptake by MDM than the clinical strains tested (p <0.001). There were no 


















Figure 3.04  Strain uptake by monocyte derived macrophages (A) Uptake of M. 
tuberculosis strains by MDM (4h CFU calculated as a percentage of initial 
inoculum). (B) Summarized uptake of M. tuberculosis strain lineages by MDM. 
H37Rv showed significantly lower uptake by the than clinical strains# (p <0.001). 
Data represent the median ± range (n= 7). 
 
To compare intracellular growth amongst different strain lineages, we determined 
a growth index, calculated from he log10 of number of CFU at each time point 
divided by the log10 of number of CFU at the 4h time point Figure 3.05. Growth of 
all clinical strains was slow for the first 24 h. Lineage 2 and lineage 4  strains grew 
faster over the first 48 h than lineage 3 strains (Lineage 3 vs. Lineage 4: p<0.01, 
Lineage 3 vs. Lineage 2: p<0.001). Lineage 2 strains grew significantly faster than 
lineage 3 strains (p<0.01) over 96 h. The mean growth index of lineage 4, lineage 2, 
lineage 3 and H37Rv was 1.19±0.22, 1.25±0.17, 1.11± 0.10 and 1.69±0.13 
respectively over 96 h. (Figure 3.05 A&B). Despite low initial uptake, H37Rv 
multiplied more rapidly in MDM than clinical strains [H37Rv vs. lineage 2 and 
lineage 4: p<0.001 at 24h and 48 h, H37Rv vs. lineage 3: p<0.001 at all-time 















strains, we also determined the doubling time of these strains. Doubling time was 
calculated based on the mean number of CFU at 4 h and 96 h (Table 3.03). The 
mean doubling time of lineage 2 strains  was 23.34 ± 3.0 h, lineage 4 strains 25.10 
± 4.67 h, lineage 3 strains 26.14 ± 2.45 h and H37Rv 17.12 ± 1.61 h (mean ± SD) 
over the 96 h time period. 
Figure 3.05 Growth index (calculated by the CFU at each time point divided 
by the CFU at initial time point) reflecting the intracellular growth of M. 
tuberculosis strains in MDM (A) Growth index of M. tuberculosis strains. (B) 
Summarized growth index of M. tuberculosis strain lineages. The data represents 
the mean ± SD (n=7). Statistical significance is denoted as *p<0.05, **p<0.01, 
***p<0.001.  
Table 3.03 Doubling time+ for M. tuberculosis strains from different lineages in 
human monocyte derived macrophages 
       Strain     Lineage         24hrs      48hrs       96hrs 
 H37Rv Laboratory   strain    13.71±2.17    13.16±1.44      17.12±1.61 
RXH24        Lineage 2    17.23±2.59     14.41±1.59      22.85±2.11 
RXH360        Lineage 2     38.99±13.2     16.31±1.82      23.47±2.11 
RXH248        Lineage 2     25.78±2.71      13.52±1.53      23.72±2.10 
CH        Lineage 3     44.97±8.9       29.79±3.75      25.60±2.09 
RXH379        Lineage 3      20.93±3.05       19.72±2.18      26.69±2.08 
RXH202        Lineage 4      35.14±7.45       18.92±2.8      23.14±2.26 
RXH266        Lineage 4      24.48±4.08       14.21±1.57      23.03±2.05 















+Doubling times G= t/3.3 log (b/B) (t= time, B= initial colonies, b= final colonies). Results 
represent mean ± S.E from n=7 donors.  
3.4.3 Effect of pre-stimulation with IFN- on growth of M. tuberculosis in 
MDM 
 
We evaluated the antimyobacterial effect of IFN- when used to pre-stimulate 
human monocyte derived macrophages prior to infection with selected strains. 
MDM were isolated from three healthy donor buffy coats supplied by South African 
Blood Transfusion Services. These donors were anonymous and they were not 
from the subset of the earlier 7 donors as mentioned in the section 3.4.2. 
Monocytes were isolated as described above and matured to macrophages for 6 
days. MDM (n=3 donors) were pre-stimulated with 100 U/ml of recombinant 
human IFN- for 24h prior to infection. As shown in Figure 3.06 (A-C) there was a 
small but consistent decrease in intracellular growth of M. tuberculosis strains in 
IFN- treated vs. untreated MDM. However, there was no clear difference between 
strains in this regard. Reduction in growth could potentially be attributed due to 
reduction in cell viability in MDM treated with IFN-  (43). We tested cell viability 
by MTT assay. The Figure 3.06 showed that cells in control wells demonstrated an 
increase in OD at the 96h time period MDMs are generally non-proliferative but 
can undergo further differentiation with prolonged culture into differentiated 
macrophages (eg. M1 and M2) with associated change in size and morphology247 

















Figure 3.06 The effect of recombinant IFN- on the growth of different 
strains of M. tuberculosis in human MDM [Without IFN-(solid line) and with 
IFN-(dotted line)]. Six day old monocyte derived macrophages were pre-treated 
with 100 U/ ml of IFN- 24 h before infection. MDM were infected with different 
strains of M. tuberculosis with MOI 1 [2X 105 MDM (106 cells/ ml) infected with 2X 
105 CFU (106 CFU /ml) of bacilli]. (A) H37Rv; (B) RXH202 (LAM3); (C) RXH24 
(Beijing). The data represent median and interquartile range (n=3). (D) Viability of 
MDM measured by MTT assay: MDM were treated with 100 U/ ml of IFN-. The 
data represent the O.D. at 570nm (median and range) for two individual donors in 





We compared lineage-specific in vitro growth phenotypes (mycobacterial growth 
in liquid broth and intracellular growth in MDM) of the two prevalent strain 
lineages (lineage 2 and 4) from the Western Cape region of South Africa with those 















In this study, the laboratory-reference strain H37Rv grew most rapidly in liquid 
culture, suggesting that H37Rv is highly adapted to laboratory media. However it is 
relevant to note that strains of H37Rv used in different laboratories may differ 
both phenotypically and genotypically248. Interestingly, lineage-specific differences 
in growth patterns in axenic media were observed, with lineage 4 strains reaching 
a higher Cmax than the other two lineages and lineage 3 strains peaking early at a 
lower Cmax. Lineage 2 strains had an intermediate phenotype. Our results are in 
lined with previous findings, which showed slow growth of Lineage 3 strains in 
7H9 broth138, 201, 237. An outbreak lineage 3 strain, CH, grew slowly in axenic 
media41. Tanveer et al. found that a CAS1 (lineage 3) strain grew more slowly in 
liquid broth than a Beijing strain and H37Rv20. Kanji et al. further demonstrated 
that a CAS1 strain with the RD149 deletion grew more slowly than H37Rv and a 
CAS1 strain with the double deletion RD149 & RD15240. 
Several previous studies have assessed intracellular growth of M. tuberculosis in 
human macrophages as a marker of virulence132, 249, 250. Different strains may vary 
in their capacity to invade macrophages. We noted lower initial uptake of H37Rv 
when compared with clinical strains. There is evidence of variation in phagocytosis 
of different strains251. For example Schlesinger et al. found that phagocytosis of 
two virulent strains (H37Rv and Erdman) by human monocyte derived 
macrophages is mediated by the mannose receptor in addition to complement 
receptor (CR1, CR3 and CR4) whereas the avirulent strain H37Ra uses only 
complement receptor for phagocytosis252. Hence, higher initial bacterial uptake by 
clinical strains (compared with H37Rv) may reflect differential expression of 
pathogen-associated molecular patterns (PAMP), which are recognised by innate 















We determined the growth index, rather than absolute growth, which expresses 
the growth of all strains irrespective of their variable uptake. We observed that 
lineage 2 and lineage 4 strains grew more rapidly in MDM than lineage 3 strains 
between 24 and 48h but that growth slowed over the next 48 h. H37Rv grew more 
rapidly than all clinical strains over the first 24 h as well as over 96h. Rapid entry 
into the phagosome through receptor mediated uptake may trigger faster 
downstream events such as endosomal sorting inside the endosomal machinery, 
which in turn may accelerate the early biogenesis of phagosome and disease 
progression253. We noted differences in mycobacterial doubling time, which was 
variable over the time period [Doubling time was calculated by the formula G= 
t/3.3 log (initial colonies / final colonies), t= time]. Torrels et al. also reported that 
doubling time of M. tuberculosis strains in MDM differs over time, which supports 
our findings251. However, there were no significant differences in doubling time 
between clinical strains over the full 96 h period, suggesting that there do not 
appear to be major differences between modern lineages in this regard. 
A growing body of literature suggests that individual strains from lineage 2 
(Beijing) grow rapidly in in vitro human cell culture models132, 203, 204. For example, 
Li et al. found several Beijing strains grew faster in human monocytes than non-
Beijing strains18. However, there are differences between lineage 2 strains in this 
regard205. Epidemiological evidence suggests that lineage 2 has recently emerged 
in the Cape Town region of South Africa121. Our findings show similar growth rates 
for the two successful strain lineages (lineages 2 and 4) in the region, which grew 
more rapidly over 48 h than lineage 3. Other recent reports have shown that 
lineage 3 strains are slow growers in the THP1 monocytic cell line when compared 















The successful intracellular survival of M. tuberculosis within macrophages has 
been attributed to various virulence determinants such as up regulation of 
principal sigma factor A (Sig A), which was found to enhance the growth of a 
lineage 2 strain254. Further, phenolic glycolipid (PGL) was shown to modulate the 
pro-inflammatory cytokine response, causing enhanced survival of a lineage 2 
strain in mice and monocytes137. Accumulation of triacylglycerol within the 
cytoplasm of lineage 2 strains may provide an additional energy source during 
infection, perhaps affording a survival advantage during intracellular infection139. 
In contrast, induction of a vigorous pro-inflammatory cytokine response by a 
lineage 4 strain was reported to restrict its survival in mice and in monocytes133. A 
genetic polymorphism in Rv 1519 was associated with supressed IL-12 induction 
and induction of increased IL-10 in a lineage 3 outbreak strain, which, although it 
demonstrated impaired growth in axenic media, was not attenuated in the MDM 
model41. Man-LAM, found in virulent strains of M. tuberculosis, antagonises 
mannose receptor-dependent IL-12 production62 and induces an anti-
inflammatory response, which enhances survival of tubercle bacilli inside 
macrophages62, 66. 
The early control of bacterial growth in tuberculosis infection relies on the 
activation of phagocytic cells, which is regulated by cytokine secretion. Various 
pro-inflammatory cytokines (such as TNF, IFN-, GM-CSF and M-CSF) are 
considered as an important mediators of macrophage activation17,255. Mutations in 
the IFN- receptor are associated with disseminated M. tuberculosis infection256. 
Exogenous administration of IFN- has improved clinical outcome of drug 
resistant pulmonary tuberculosis patients257. IFN- stimulation has been shown to 















nitric oxide (NO) in mice. The anti-mycobacterial property of NO in macrophages 
has been well documented in mice222, 258, however, the role of iNOS in human M. 
tuberculosis infection remains controversial259-262. There is evidence of expression 
of NOS2 in macrophages from tuberculosis bronchoalveolar lavage specimens263, 
264. Furthermore, there is evidence of NO production in human monocytes, 
macrophages, and a human monocytic cell line when infected with M. 
tuberculosis265, 266.  However, previous findings have demonstrated that a NO-
independent TLR2 pathway mediates antimicrobial activity in human 
macrophages42. In contrast, a recent study by Lee et al. demonstrated that 
combined treatment with Vitamin D (1,25 D3) and IFN- augmented NO synthesis 
and iNOS expression in monocyte-derived macrophages, which was mediated by 
NO-dependent TLR2 pathways267.  The early literature has conflicting reports on 
the effect of exogenous IFN- on the ability of human macrophages to kill M. 
tuberculosis, with some of these studies describing increased killing268 and others 
enhanced growth of M. tuberculosis269 The anti-microbial activity of IFN- is likely 
to be dependent on its concentration and timing of administration. Stimulation 
with higher concentrations of IFN- could be harmful during MDM differentiation. 
We noted a slight, but consistent decrease in M. tuberculosis growth in MDM, pre-
stimulated with IFN-. There was no clear association between the effect of IFN- 
and the genotype of the infecting strain. We did not measure the NO level during 
infection. Since only two clinical strains and one laboratory strain were tested 
these findings should not be extrapolated more broadly. 
MDMs are generally non-proliferative but it could undergo further differentiation 
into different macrophages (eg. M1 and M2) with changes in its size and 















under microscope as generally advised prior to MTT assay.  The data in control 
wells were in replicates and reproductive, suggest an increase in OD during MTT 
assay due to increase in formazan formation. Cells in the control wells were 
supplemented with RPMI and foetal calf serum (FCS) and cells were healthy and 
happily growing cells. In presence of nutrient medium cells in the control well 
might be further differentiated and changed in its morphology and size. Healthy 
cells in control wells could produce high amount of mitochondrial enzyme 
dehydrogenase, which might produce more formazan in 96 h time period. IFN- 
treated cells were activated and highly sensitised. Evidence suggests that MDM 
activation with pro-inflammatory (including IFN-) and anti-inflammatory 
molecule showed reduction in cell viability. Therefore, the decrease in OD 
observed in IFN- treated wells could be due to reduction in cell viability. 
Furthermore, IFN- is cytotoxic in nature and prolong activation might cause 
damage in cells. Previous studies showed that immunomodulator could sensitize 
the MDM such an extent that monolayer get destroyed causing death of the cells269-
271. Therefore, it is not clear to what extent the decrease in cell viability 
contributed to the effect of IFN-  on mycobacterial growth.  
There are a number of limitations of this in vitro model. Short term growth in 
macrophages only partially reflects the more lengthy and complex pathogenesis in 
humans, we were unable to distinguish bacterial uptake from simple adherence to 
macrophages and PBMC-derived macrophages differ phenotypically from alveolar 
macrophages272. Rapid growth in macrophages may not necessarily represent a 
virulence characteristic206. Furthermore, due to the limited number of MDM 
available, we were only able to compare a few strains from each lineage. All of 















represent specific sub-lineages. They do not therefore represent the global 
diversity of ‘modern’ TB strains.  
In summary, we have demonstrated that the laboratory reference strain grew 
faster than clinical strains and that lineage-specific difference in growth patterns 
in axenic media were observed, with lineage 4 strains reaching a higher Cmax than 
the other two lineages and lineage 3 strains peaking early at a lower Cmax. Lineage 
2 strains had an intermediate phenotype. We also observed initial uptake of H37Rv 
by MDM was lower as compared to clinical strains but that it grew faster in MDM 
than the clinical strains. Moreover, selected lineage 2 and lineage 4 strains grew 
faster in MDM than the lineage 3 strains. Pre-stimulation of IFN- resulted in an 
















Induction of cytokine responses by M. tuberculosis 
strains from modern lineages 









































Cytokines, potent mediators of body’s immune response, are produced by different 
immune cells (such as macrophages, dendritic cells and T cells) following infection 
with M. tuberculosis74, 75, 89. Cytokines regulate the immune response and also have 
effector functions. They play a key role in control of tuberculosis infection and 
serve as a marker of severity of tuberculosis infection75, 108, 204, 273, 274. Several 
investigators have suggested that suppression of protective cytokine responses by 
M. tuberculosis is a key pathological mechanism in disease275-278. 
Human cytokine levels can be measured in tuberculosis infection using in in vivo279 
(in lungs or in circulation) or ex vivo model systems (in isolated cells)133, 216, 280, 281. 
In vitro studies have measured human cytokines following infection with M. 
tuberculosis using whole blood assays219, 282, 283, primary cell isolates (mononuclear 
cells separated from peripheral blood mononuclear cells [PBMC])136, 284 or using 
commercially available monocytic cell lines such as THP-1201, 204. Key cytokines 
involved in the control of tuberculosis infection are produced by mononuclear 
phagocytes (including tumor necrosis factor (TNF), interleukin-12 (IL-12), 
interlukin-1 (IL-1) interleukin-10 (IL-10) and interlukin-6 (IL-6))14, 285.  
The Th1 cytokine response is important in control of tuberculosis infection286 and 
IL-12 plays a crucial role in inducing a protective IFN- (Th1 response) response, 
which is associated with activation of macrophages to kill intracellular M. 
tuberculosis34, 287. The key role of TNF in protective immunity in tuberculosis 
infection, and in maintaining granuloma formation, is demonstrated by studies 
showing reactivation of latent tuberculosis infection following use of therapeutic 















inflammatory response, macrophage activation, chemokine secretion and 
recruitment of monocytes, neutrophils, and lymphocytes to the infection site to 
form the granuloma14, 76, 77.  
In animal models, high levels of pro-inflammatory cytokines have been associated 
with increased survival of mice when infected with different M. tuberculosis 
strains130, 135. For example, CDC1551 (a lineage 4 strain) has been shown to induce 
vigorous cytokine response in mice resulting in prolonged survival of mice when 
compared to lineage 2 (Beijing) strains such as HN878 and HN60, which fail to 
induce strong pro-inflammatory responses14. In in vitro macrophage models of 
human infection, reduced levels of pro-inflammatory cytokine secretion have been 
associated with higher intracellular growth rates138, 204, 250.  
Several in vitro studies have described diverse cytokine responses induced by 
various genotypes of M. tuberculosis136, 137, 201, 204, 216, 219, 280, 289. For instance the 
outbreak strain CDC1551 (lineage 4 strain, X family strain) induced rapid and high 
levels of pro-inflammatory cytokines such as TNF, IL-6 and IL-12133. Another 
outbreak strain, CH (lineage 3 strain, CAS strain), was found to produce less 
protective IL-12p40 and more anti-inflammatory IL-10 than the reference strain 
H37Rv284.  
In this part of the study, we used strains representative of two predominant 
lineages from Western Cape region of South Africa lineage 4 and lineage 2, as well 
as comparator strains from the less prevalent lineage lineage 3. We elected to use 
human primary monocyte-derived macrophages (MDM) as a model to evaluate 
early cytokine response in M. tuberculosis infection. We were only able to assess 















compared, and the amount of supernatant obtained from the intracellular MDM 
infection was limited in the 96-well plate format used. These cytokines were 
selected because of their important role in early tuberculosis infection14, 219, 280, 284. 
4.2 Aims of the study 
 
 To determine the time course of TNF and IL12p40 responses human MDM 
infected with different modern strains of M. tuberculosis.  
 To determine patterns of TNF and IL-12p40 production by MDM infected 
with different modern strains of M. tuberculosis.  
4.3 Methods  
 4.3.1 Subjects 
 
The experiment was conducted with human primary monocyte derived 
macrophages (MDM). Monocytes were isolated from healthy donors buffy coats 
supplied by South African Blood Transfusion Services. The samples were provided 
without donor identifiers; therefore demographic information was not available. 
The 6 donors selected to measure IL-12p40 were subset of 8 donors selected to 
measure TNF response. The study was conducted with ethical approval from the 
Research Ethics Committee, Faculty of Health Sciences, University of Cape Town 















4.3.2 M. tuberculosis strains 
The time course experiment was performed with three lineage 2 strains [(RXH 24, 
RXH 65, RXH 169) and three lineage 3 strains (CH, CH1519 and CH1996) and 
H37Rv]. Subsequently we used the different panel of strains as described in 
Chapter 3 (which includes lineage 4 strains) to perform various growth assays and 
to investigate cytokine induction at the 48h time point. 
4.3.3 Monocyte derived macrophage infection model 
 
Monocytes were isolated from healthy donors, matured to macrophages, and 
infected with M. tuberculosis strains from different modern lineages. Culture 
supernatants were harvested following post infection at specific time points and 
stored at -800C until ELISA was performed. TNF and IL-12p40 levels were 
measured in filtered sterilized culture supernatant using ELISA (BD Biosciences 















We conducted a time course experiment to measure TNF and IL-12p40 at three 
different time points after infection (24h, 48h and 72h) in which 106 cells (n=5) 
were infected with 106 CFU of bacteria in 24 well flat bottom plates. These 
experiments were conducted with larger numbers of cells than later experiments, 
where we had refined the technique to utilize smaller cell numbers and allow 
comparison of more strains. For the comparison of larger numbers of strains, we 
selected the 48h time point for measurement of TNF and IL-12p40 levels. For these 
experiments, due to limited numbers of MDM, we used a 96-well format, in which 
2x105 cells were infected with 2x105 CFU of bacteria in 96 well flat bottom plates. 
The six donors selected in this section to measure IL-12p40 were a subset of the 8 
donors selected to measure TNF responses (where sufficient cells were obtained). 
4.3.4 Cytokine measurement by ELISA 
 
Sandwich ELISAs were performed to determine cytokine levels in cell 
supernatants. Microtiter plates were coated with 100 µl purified capture antibody 
of IL-12p40 or TNF (BD Pharmingen) diluted in phosphate buffered saline (PBS, 
pH 9.5) and incubated o ernight at 4°C. Plates were aspirated and washed 3 times 
with 300 µl/ well wash buffer (PBS with .05% Tween 20). Plates were blocked for 
1h at room temperature and aspirated and washed three times. Serially diluted 
100 µl purified recombinant IL-12p40 or TNF standards (BD Pharmingen) were 
used as standard curves. 100 µl cell supernatants were then added diluted in 
ELISA assay diluent and incubated for 3h at room temperature. Plates were 
washed 5 times and 100 µl of secondary detection antibodies conjugated with 
Streptavidin-horse radish peroxidase (Save-HRP) for IL-12p40 or TNF (BD 
Pharmingen) added to each well for 1h at room temperature. ELISA wash buffer 















substrate (tetra-methyl-benzidine), for 10 minutes in room temperature in the 
dark and the reaction was stopped using stop solution (1M H3PO4 or 2 N NH2SO4). 
Absorption was measured at 450 nm using a Bio-Rad spectrophotometer. 
4.3.5 Statistical analysis 
 
Graphpad Prism 5.00 was used for statistical analysis of cytokines. The normality 
of the data was assessed by the D’Agostino & Pearson omnibus normality test. 
Since cytokine data were not normally distributed, cytokines were compared using 
the unpaired, non-parametric Mann Whitney test.  
4.4 Results 
 
Firstly, in order to determine the optimal time point for TNF sampling, we 
measured TNF levels at 24 h, 48 h and 72 h post infection of MDM. Secondly, in 
order to find out whether there was any pattern of cytokine induction 
characteristic of different M. tuberculosis lineages, we investigated TNF and IL-
12p40 production at the 48 h time point. 
 4.4.1 Production of TNF by MDM infected with M. tuberculosis strains at 
different time points 
 
To determine the optimal time point for sampling post infection, supernatant was 
collected at various time points (24h, 48h and 72h) and cytokine response (TNF 
and IL-12p40) measured by ELISA (Figure 4.01). MDM infected with lineage 3 
strains and the laboratory strain H37Rv induced higher amount of TNF at all the 
time points compared with lineage 2 (Beijing) strains (H37Rv vs. lineage 2 
p=0.001, lineage 3 vs. lineage 2 p= 0.001). IL-12p40 secretion was significantly 















0.04) at the 48h time point. Since there was no significant difference in TNF 
response at different time points and IL-12p40 level was higher in MDM infected 
with H37Rv at the 48h time point we selected the 48h time point for further 
experiments. 
  
Figure 4.01 Production of TNF and IL-12p40 by MDM infected with M. 
tuberculosis strain lineages at different time points. Data from 5 donors; 106 
cells were infected with 106 CFU of bacteria per well. TNF p values: H37Rv vs. 
lineage2 =0.001, lineage 3 vs. lineage 2 =0.001.Induction of IL-12p40 was 
significantly higher in MDM infected with H37Rv than the lineage 2 strains 
(p=0.04) at 48 h time point Data represent in the median and range.  
 
4.4.2 Production of TNF and IL-12p40 by MDM infected with M. tuberculosis 
strains at 48 h 
 
ELISA was performed on supernatant collected at 48 h post infection to measure 
the release of TNF and IL-12p40 from monocyte-derived macrophages (MDM) 
following infection with M. tuberculosis strains (Figure 4.02). MDM infected with 
Lineage 2 strains and Lineage 3 strains induced lower levels of IL-12p40 when 















lineage 3 =123.8 ± 10 pg /ml, median and range, p<0.001) and lineage 4 strains 
(lineage 4 = 205 ± 15 pg /ml, p<0.001, median and range) (Figure 4.02 A).  
 
Figure 4.02 Cytokines detected in culture-supernatant (at 48h) from MDM 
infected by different strains of M. tuberculosis (A) IL-12p40 (n=6 donors). 
H37Rv and lineage 4 strains induced significantly higher level of IL-12p40 as 
compared lineage 3# and lineage 2# lineages (p<0.001 for both comparisons) (B) 
TNF (n= 8 donors). Lineage 3 strains induced significantly higher levels of TNF as 
compared to lineage 2# (p=0.001), lineage 4 * (p<0.05) and H37Rv** (p=0.01). 
H37Rv and lineage 4 strains induced higher level of TNF than lineage 2 strains 
(lineage 4 vs. lineage 2 p = 0.001, H37Rv vs. lineage 2 p= 0.01). Data represent in 
the median and range. 2X105 cells were infected with 2X105 CFU of bacteria per 
well. Data represent in the median and range. 
 
Further, the release of TNF by MDM infected with lineage 2 strains was 
significantly reduced when compared with both, H37Rv (H37Rv= 1253 ± 84 pg 
/ml, lineage 2= 362 ± 28 pg /ml, p<0.01, median and range) and other lineages 
(lineage 3= 1818 ± 123 pg /ml, p<0.001; lineage 4 = 1207 ± 112 pg /ml, p<0.001, 
median and range) [Figure 4.02 B]. In contrast to IL-12p40, higher levels of TNF 
were induced by MDM infected with lineage 3 strains when compared to H37Rv (p 
<0.01) and lineage 4 strains (p<0.05). Induction of both TNF and IL-12p40 was 






















































































































































different between these lineages (TNF: p= 0.556; IL-12p40: p=0.0574, medians are 
significantly different if p<0.05). 
4.5 Discussion 
 
We have demonstrated that the pro-inflammatory cytokine (TNF and IL-12p40) 
profiles induced by representatives of the three major modern strain lineages of M. 
tuberculosis [lineage 4, lineage 2 and lineage 3] are distinct.  
The collective evidence from several in vitro studies reinforces the view that M. 
tuberculosis strains induce variable innate immune responses201, 204, 216, 284. 
However, the cytokine response may differ with the experimental model due to 
bacterial strains, stimulation conditions, time course and the cells used in the 
experiment. Several studies have reported that heterogeneity exists in the cytokine 
response induced by various genotypes of M. tuberculosis216, 284. Recently, modern 
lineages (lineage 2, lineage 4, lineage 3) were shown to induce lower levels of pro-
inflammatory cytokines in GM-CSF derived macrophages and monocyte derived 
dendritic cells when compared with ancient lineages [lineage 1(Indo-Oceanic), 
lineage 5 (West-African-1) and lineage 6 (West-African-2)]280. Moreover, in a 
recently reported study from Madagascar PBMC infected with strains from modern 
lineages (Beijing and CAS strains) produced low levels of antigen-specific 
protective IFN- response when compared with strains from ancient lineages 
(Indo Oceanic lineage), suggesting that modern strains might have evolved 
mechanisms to suppress production of IFN- which may provide a selective 
advantage to such modern strains289. 
The results from the present study demonstrate that strains from modern lineages 















similar levels of pro-inflammatory cytokines to the reference strain H37Rv (also a 
lineage 4 strain). This finding is compatible with previous findings that lineage 4 
strains (including Harlem and LAM strains) induced similar patterns of TNF, IL-6, 
IL-10, and GRO- α as H37Rv in human macrophages216. The outbreak strain, 
CDC1551, which is a representative of the lineage 4 (belonging to the X family), 
also induced high levels of pro-inflammatory cytokines in monocyte culture133, 136.  
Furthermore, in this study the selected Beijing strains induced low levels of pro-
inflammatory cytokines (TNF and IL-12p40). This finding is in line with previous 
findings of low level cytokine induction (TNF, IL-6, IL-10 and GRO-α) by lineage 2 
strains, irrespective of subfamily, in human macrophages216. Low pro-
inflammatory cytokine induction by individual lineage 2 strains has been reported 
in various human cell culture models including human monocyte-derived 
macrophages and THP1 cell line137, 204, 206, 216, 219, 290. In contrast, a recent study 
demonstrated that ‘ancient’ lineage 2 strains from Brazil (characterized by the 
absence of IS6110 within the [NTF]) induced similar levels of TNF and IL-10 to 
H37Rv whilst ‘modern’ multidrug-resistant Beijing strains isolated in Russia, 
induced low TNF and high IL-10 in the THP1 macrophage cell line290. Tanveer et al 
found lineage 2 strains to produce a weaker IFN-γ and TNF response in THP1 cells 
as compared to H37Rv (23). In animal models, lineage 2 strains inducing a poor 
Th1 response caused earlier death of mice, compared with comparator strains129, 
130, 135. Several human and animal studies have suggested that the propensity of 
lineage 2 strains to induce lower levels of protective Th1 cytokines (such as TNF, 
















In our study, Lineage 3 strains were found to induce high levels of TNF and low 
levels of IL-12p40. Our findings are in line with those of Newton and colleagues284 
who described high TNF and a low IL-12p40 secretion by MDM infected with a 
lineage 3 strain. However, other Lineage 3 strains have been reported to either 
induce similar levels of pro-inflammatory cytokines to lineage 2 strains (low 
levels) (23) or to induce similar levels as H37Rv (higher levels)216, 219, 284. A recent 
study by Kanji et al. found that all lineage 3 induce higher levels of TNF but that the 
RD149 deleted sub lineage of CAS1 strains (lineage 3) induce more TNF than the 
CAS1 strains (lineage 3) without the RD149 deletion in THP1 cells. CAS1 strains 
(with the RD149 deletion) from extra-pulmonary sites of infection induced lower 
level of TNF than those isolated from pulmonary sites201.  
In summary, we have demonstrated that different modern M. tuberculosis lineages 
exhibit lineage-specific patterns of IL-12p40 and TNF induction, with lineage 4 
strains inducing high levels of both cytokines, lineage 2 strains low levels of both 
cytokines and lineage 3 strains high levels of TNF but low levels of IL12p40. This 
study suggests that modern strain lineages of M. tuberculosis may possess lineage-
specific patterns of growth and cytokine induction. These in vitro characteristics 
may reflect different strategies that M. tuberculosis employs to exploit ecological 






















The interaction between strain lineage and host 
population: cytokine responses in the monocyte-



































The global distribution of M. tuberculosis strain genotypes is not uniform, with 
particular strain lineages, or combinations of lineages, predominating in certain 
geographical areas111, 112, 117, 141. One explanation for this finding is that 
evolutionary selection pressure is a function of both host and bacterial genetics, 
and a result of long-term host pathogen interaction.  Since disease outcome is 
likely to be determined by the interaction between bacteria with the host immune 
system, variation in both host and bacterial factors is likely to influence this 
interaction.  
Variation in the host immune response may partly explain variation in the 
susceptibility to tuberculosis amongst individuals. Several polymorphisms have 
been reported in genes encoding various innate immune molecules (e.g. NRAMP1, 
iNOS), macrophage receptors (e.g. TLRs, Mannose receptors   [MR, CD 206], 
Vitamin D receptor [VDR]) and cytokines53, 90, 291-293. For example, Natural 
Resistance Associated Macrophage Protein 1 (NRAMP1, encoded by SLC11A1) is an 
integral membrane protein, which is found to be present in the lysosome 
compartment of monocytes and macrophages, and is involved in iron metabolism 
and macrophage activation. A number of studies have reported that 
polymorphisms in SLC11A1 genes are associated with tuberculosis disease 
susceptibility amongst Asian and African populations294-297. Polymorphisms in the 
gene encoding the vitamin D receptor (VDR) have reported to be associated with 
hydroxyl cholecalciferol deficiency and susceptibility to tuberculosis in the 
Gujarati Indian community in the United Kingdom292. Functional defects in genes 















fatal mycobacterial infection in patients, as a result of defective IFN- signalling 
and a poor Th1 response.  
On the other hand, despite exhibiting relatively lower DNA sequence variation 
than many other pathogenic organisms; the role of pathogen variation is emerging 
as an important determinant of the outcome of infection301-303. Decades of animal 
studies have reported phenotypic diversity in M. tuberculosis strains129, 131, 133. 
Recently, in in vitro models of human infection have suggested that strain diversity 
amongst M. tuberculosis exists influences growth or cytokine induction201, 203, 216, 
217, 237. A number of in vitro and in vivo studies have reported that different 
genotypes of M. tuberculosis induce distinct patterns of immune responses216, 217, 
237. Epidemiological evidence demonstrates that three modern lineages (lineages 2, 
3 and 4) are highly successful in different parts of the world. Whilst this may be 
due to a founder effect and subsequent expansion of human populations in Europe, 
India, and China, it is also possible that these lineages have selective advantage 
over other (particularly ancient) lineages 112(Fig 5.01).  
 
Figure 5.01 Global distribution of MTB Complex based on whole genome 















For example, lineage 2 strains were associated with treatment failure304, relapse, 
drug resistance171, 304, 305, febrile response306, extrapulmonary tuberculosis and 
meningeal tuberculosis307. Caws et al. reported that lineage 4 strains were 
associated with pulmonary disease in Vietnamese adults (rather than the 
extrapulmonary disease)307. Lari et al. found that lineage 3 strains are associated 
with extrapulmonary disease301. However, these findings are not often consistent 
and vary between settings188. Lineage 2 strains were found to be associated with 
TBM in immune suppressed HIV patients in a Vietnamese population302, indicating 
an association between host immune status and a lineage known to be associated 
with immune subversion, resulting in more severe tuberculosis disease phenotype. 
The above evidence suggests that host and bacteria both have an influence on 
tuberculosis disease outcome. The interplay between different bacterial strains 
and hosts from different population groups adds an additional level of 
complexity303, 307-310. For example, studies have reported that polymorphisms in 
TIRAP (C558T) and TLR2 (T597C) genes are associated with increased risk of 
tuberculosis meningitis (TBM) in Vietnamese patients53, 311, indicating that 
polymorphisms in host immune receptors may influence the clinical disease 
phenotype. Subsequently a study from Vietnam for the first time established an 
association between M. tuberculosis genotype and host genetic background. In this 
study, Caws et al. demonstrated that a polymorphism in TLR2 (T597C) is more 
commonly found in Vietnamese adult TBM patients infected with lineage 2 strains 
than those infected with other strains307. Further, a study from Indonesia 
identified an association between two SCL11A1/ NRAMP1 polymorphisms (D543N 
G allele and 3’ untranslated region insertion/ insertion genotype) and lineage 2 















Immune leukotrines (LTs) and lipoxins (LXs) are important airway inflammatory 
mediators (abundant in smooth muscles and small vessels in airway passage) and 
regulate adaptive and innate immunity by enhancing cytokine production309. LTs 
and LXs are synthesized by 5-lipoxygenase (ALOX5) from a precursor, arachidonic 
acid309. LTs function as pro-inflammatory cytokine mediators whereas LXs are 
anti-inflammatory in nature. LTB4- (a type of LT) mediated phagocytosis of 
microorganisms has been reported in alveolar macrophages and 
polymorphonuclear leucocytes (PMN)309. An exonic non-synonymous 
polymorphism (g.760A) in ALOX5 was found to be associated with TB in a 
Ghanaian case control study of 1916 sputum positive TB cases and 2269 healthy 
controls. Furthermore, the association was strongest in TB cases infected with the 
M. africanum West-african-2 lineage (lineage 6)309, suggesting an association 
between host and pathogen genotypes.  
These findings support the hypothesis that polymorphisms involving host 
immunity may regulate susceptibility to tuberculosis disease in certain human 
populations, and that the degree of susceptibility may differ with the genotype of 
the infecting strain.  
Polymorphisms in host and bacterial genotypes have been found to influence 
innate immune responses to tuberculosis53, 137, 138, 307. In vitro infection of 
monocyte, macrophage and dendritic cells with M. tuberculosis strains induces 
various inflammatory (TNF, IL-12p40, IL-6 etc.), anti-inflammatory (IL-10) and 
chemokine (MIP-1, MIP-1, IL-8 etc.) mediators. However, these cytokines are 
differentially expressed in different donors217, 312, 313. Moreover, various in vitro 
and in vivo studies have demonstrated that M. tuberculosis genotypes produce 















with variation in virulence, immunopathology and transmission. However, it is not 
clear how such variation in the immune response to different strains is linked to 
differences between human population groups. We therefore hypothesized that 
the immune response to strains from different genotypes would vary depending 
on the population group of the host. 
5.2 Aims of the study 
 
 To compare the early cytokine response in MDM infected in vitro with 
strains of M. tuberculosis from different lineages including three modern 
and one ancient M. tuberculosis lineage.  
 To determine whether the early cytokine response in MDM infected in vitro 
with strains of M. tuberculosis from different lineages differs amongst 
various population groups. 
 To investigate the interaction between M. tuberculosis genotype and host 
population group as determined by cytokine response in the MDM model. 
5.3 Methods 
5.3.1 Ethical Considerations 
 
The study was conducted with ethical approval from the Faculty of Health Science 
Research Ethics Committee, University of Cape Town (REC REF 261/2008). 





















5.3.2 Description of MDM donors 
 
Healthy blood donors from five different ethnic groups: Black (Xhosa-speaking), 
Coloured (mixed ancestry), White (Caucasian), Indian and Chinese from Cape 
Town were included in the study. The ethnicity of the blood donors was self-
defined. Participants were primarily recruited from amongst staff and students at 
the University of Cape Town. All volunteers gave written informed consent for 
donating blood and HIV testing. HIV testing was performed in conjunction with pre 
and post-test counselling by trained nurse counsellor. HIV infected individuals 
were referred to the appropriate health service for further management and 
excluded from the study. 
Table 5.01 Description of demographic features of blood donors. 
 
5.3.3 M. tuberculosis strains 
 
In this study cytokines and chemokine responses were measured in MDM infected 
with strains from the three modern lineages as described in chapter 2 [lineage 2 
(RXH24, RXH248, RXH360), lineage 4 (RXH202, RXH266, RXH6) and lineage 3 (CH 
and RXH379)] as well as an ancient lineage strain (Lineage 1 MANU strain IND30, 
kindly provided by Dr Nerges Mistry, Foundation for Medical Research, Mumbai, 
India). 
Characteristics                                               Ethnic Groups 
                                       Black              Coloured           Chinese            White         Indian 
 
Age (mean ±SD)        409                   276               265               286.1         265.24  
Gender (n= 69)            15                          7                     15                      16                     16 
Male                                  4                           0                     6                          4                       8  
















5.3.4 MDM infection  
 
Blood samples (50 ml) were collected from healthy donors into vacutainer tubes 
containing preservative-free heparin. Monocytes were isolated and matured to 
macrophages and infected with different M. tuberculosis strains as described in 
Chapter 3. Culture supernatants were harvested at a single time point 48h post 
infection and stored at -800C until assayed. Supernatants were analysed using the 
MILLIPLEX

 Multi analytes Profiling human cytokine/chemokine analytes 
premixed kit (Millipore Corporation, Missouri, USA) on the Luminex system.   
Lineage          Population 
_______________________________________________________________________________________ 
Lineage 1         Black 
 
Lineage 2          Coloured 
 
Lineage 3          White 
 
Lineage 4          Indian 
 
            Chinese 
Figure 5.02 Schematic representation of MDM infection model- MDM isolated 
















5.3.5 Detection of Cytokines by Luminex multiple cytokine assay 
5.3.5.1 Principle 
 
MILLIPLEXTM Multi Analyte Profiling (MAP) is based on Luminex® xMAP® 
technology. In this technique, microspheres are internally coloured with two 
fluorescent dyes (red and infrared) in varying concentrations. Up to 100 such 
distinctly coloured bead sets are prepared, in which each bead is coated with a 
particular capture antibody. The capture antibody-coated microsphere beads 
capture multiple analytes from a single test sample. This step is followed by 
incubation with a biotinylated detection antibody, which is further conjugated 
with a reporter molecule (streptavidin –PE conjugate) to complete the reaction on 
the surface of microsphere. The immune complex microsphere is then passed 
through a laser, which excites the internal dyes marking the microsphere beads. 
Further, a second laser is used to excite the fluorescent dye (PE) on the reporter 
molecule.  Finally, a high-speed digital-signal processor identifies each individual 
microsphere and quantifies the results of its bioassay based on the fluorescent 
reporter signals. 
5.3.5.2 Cytokine assessment 
 
Multiple cytokine analysis in M. tuberculosis-infected cell culture supernatants was 
performed using the Milliplex MAP kit. The assay was accomplished in 96 well 
micro titre plates according to manufacturer’s instructions. Briefly, the filter plate 
was pre-wetted using assay buffer and excess assay buffer was decanted by 
vacuum filtration.  Internal controls and standard were set up ranging from 0 to 
10,000 pg/ml for each experiment.  After addition of samples to appropriate wells, 
beads were added to each well and plates were incubated for 1 hour at room 















sequentially added for 30 min and the plate was analysed on a Luminex 200 
analyser. Results were analysed as described below. 
5.3.6 Statistical Analysis 
 
 We performed univariate analysis on cytokine data using Graphpad Prism 5. M. 
tuberculosis induced cytokine responses were background subtracted (from 
uninfected) and,  where this resulted in negative values, the negative values were 
adjusted to zero by adding small positive constant (+1) value assigned to the 
complete data set. Normality was tested by Shapro-wilk’s normality test. 
Nonparametric data was analysed by one-way ANOVA and Dunnet’s post hoc test.  
Linear modelling and Principal Component Analysis (PCA) were used to determine 
whether M. tuberculosis lineages induce specific patterns of cytokine secretion in 
individual population groups. Analysis was performed using Qlucore Omics 
Explorer 2.2 (Qlucore). Prior to analysis, cytokine concentrations were log2-
transformed and normalized to the mean for each analyte with variance −1 to +1. 
Missing values (resulting from absence of particular sample or inadequate volume 
for determining concentration of a given analyte) were imputed by K nearest 
neighbours (k-NN), where a positive constant value (K) is generated to replace the 
missing value according the level of that cytokine in the most closely correlated 
sample. Inter-individual variation within population groups was adjusted using the 
eliminated factors approach applied to the sample annotation ‘donor ID’ which 
generated a General Linear Model to normalise baseline differences between 
donors. Lineage-specific differences were identified by ANOVA, with significance 
set at p-value and q-value <0.05. The q-value is a measure of false discovery rate, 















values is a measure of their Pearson correlation. The correlation between 
significant analytes was analyzed by network PCA. The distance between the 
analytes in their network represents their Pearson’s correlation coefficient and 
analytes are connected by a line to the analyte to which they are most closely 
correlated (1st nearest neighbor).  
Further, in order to assess possible interactions between M. tuberculosis lineage 
induced cytokine responses and human ethnicity, we performed multivariate 
analysis using mean rank values (log10) of cytokine concentration analysed using 
repetitive measure ANOVA.  
5.4 Results 
5.4.1 Cytokine responses to infection of macrophages from different human 
population groups by M. tuberculosis strains from different lineages  
 
The supernatants obtained after 48 h of in vitro MDM infection with various M. 
tuberculosis strain lineages were assayed by Luminex multiple cytokine assay to 
detect various cytokines and chemokine levels. The initial analysis described 
below was a simple individual cytokine comparison between lineages (Table 5.02) 
and between population (Table 5.03) groups without consideration of the 























Tumour necrosis factor 
 
Figure 5.03 TNF response following infection of MDM with M. tuberculosis strain 
lineages (left) and in different population groups (right).  Box and whisker plots 
represent the 25th and 75th quartiles and the horizontal represents the median of 
TNF response.  
 
Overall, TNF response to infection with lineage 4 strains was higher when 
compared to lineage 1 (p<0.01) and lineage 2 (p<0.001) strains. Lineage 3 strains 
induced intermediate responses, which were significantly higher than to lineage 2 
strains (p<0.001). We also compared the TNF response in various population 
groups irrespective of M. tuberculosis strain lineage. TNF level was significantly 
higher in the Chinese population than the Coloured population (p<0.001). There 
























Figure 5.04 IL-6 response following infection of MDM with M. tuberculosis strain 
lineages (left) and in different population groups (right).  Box and whisker plots 
represent the 25th and 75th quartiles and the horizontal represents the median of 
IL-6 response.  
As for TNF, highest IL-6 levels were induced by lineage 3 and 4 strains. Lineage 2 
strains induced lower levels of IL-6 as compared to lineage 4 and lineage 3 strains 
(p<0.001), whilst IL-6 response to the lineage 1 strain was intermediate and lower 
than that to lineage 4 strains. There was no significant difference in IL-6 levels 
amongst different population groups. 
Interleukin -12p40 
 
Figure 5.05 IL-12p40 response following infection of MDM with M. tuberculosis 
strain lineages (left) and in different population groups (right).  Box and whisker 
plots represent the 25th and 75th quartiles and the horizontal represents the 
















IL-12p40 responses were low, however the pattern of IL-12p40 responses was 
similar to the previous two (TNF and IL-6) inflammatory cytokines. Lineage 4 
strains induced higher levels of IL-12p40 as compared to lineage 2 (p<0.001) and 
lineage 1 strains (p<0.01). The lineage 3 strains induced intermediate levels of this 
cytokine and significantly higher levels than the lineage 2 strains (p<0.05).  These 
results are similar to those described in chapter 4, where we measured IL-12p40 
level in MDM with small numbers of donors from blood donor buffy coats. There 
was no significant difference in IL-12p40 levels amongst the different population 
groups. 
 Granulocyte Macrophage-Colony Stimulating Factors 
 
 
Figure 5.06 GM-CSF response following infection of MDM with M. tuberculosis 
strain lineages (left) and in different population groups (right).  Box and whisker 
plots represent the 25th and 75th quartiles and the horizontal represents the 
median of GM-CSF response.  
 
GM-CSF showed a similar pattern of responses to the other class I cytokines as 
described here. Lineage 4 strains induced higher levels of GM-CSF as compared to 
lineage 2 (p<0.001) and lineage 1 strains (p<0.001). Lineage 3 strains induced 















by lineage 2 strains (p<0.01). There was no significant difference in GM-CSF 
responses amongst the different population groups. 
Interleukin-1 
 
Figure 5.07 IL-1β response following infection of MDM with M. tuberculosis strain 
lineages (left) and in different population groups (right).  Box and whisker plots 
represent the 25th and 75th quartiles and the horizontal represents the median of 
IL-1β response.  
IL-1 levels were significantly higher in response to infection with lineage 4 strains 
than lineage 2 strains (p<0.01). Lineage 1 strains and Lineage 3 strains induced 
intermediate levels of IL-1. As for TNF, the Coloured population showed lower 
level of IL-1 responses than the Chinese population (p<0.05). There was no 
significant difference in IL-1 level amongst other population groups. 
Interleukin-10    
 
 
Figure 5.08 IL-10 response following infection of MDM with M. tuberculosis strain 















represent the 25th and 75th quartiles and the horizontal represents the median of 
IL-10 response.  
 
 
IL-10 levels were maximum in response to lineage 4 and lineage 3 strains. Lineage 
4 strains induced significantly higher levels of IL-10 than lineage 2 and lineage 1 
strains (p<0.01). There was no significant difference in IL-10 levels amongst 
different population groups. 
Macrophage Inflammatory Protein -1 (CCL3) 
 
  
Figure 5.09 MIP-1α response following infection of MDM with M. tuberculosis 
strain lineages (left) and in different population groups (right).  Box and whisker 
plots represent the 25th and 75th quartiles and the horizontal represents the 
median of MIP-1α response.  
There was no significant difference in MIP-1 level in response to different strain 























Macrophage Inflammatory Protein -1 (CCL4) 
 
 
Figure 5.10 MIP-1β response following infection of MDM with M. tuberculosis 
strain lineages (left) and in different population groups (right).  Box and whisker 
plots represent the 25th and 75th quartiles and the horizontal represents the 
median of MIP-1β response.  
Lineage 4 and lineage 3 strains induced higher levels of MIP-1 β than lineage 2 
strains (p<0.001), whilst lineage 1 strains induced intermediate levels of this 





Figure 5. 11 IL-8 response following infection of MDM with M. tuberculosis strain 
lineages (left) and in different population groups (right).  Box and whisker plots 
represent the 25th and 75th quartiles and the horizontal represents the median of 















High levels of IL-8 were produced by MDM infected with all the strain lineages of 
M. tuberculosis. However, there was no significant difference in IL-8 levels in 
response to different M. tuberculosis lineages. Similarly, there was no significant 





















                
                 






















      IQR – Interquartile range between 25th and 75th percentile.   
                      Cytokine responses are background-subtracted values. 
Cytokines Lineage 4 
Median (IQR) 
Lineage 3 
 Median (IQR) 
  Lineage 2 





TNF 2503 (669-6467)  1361 (279-5627)  550 (133-1285)  908.9 (201-2996)  81.58  (24.69-299.7) 
IL-6                              1405 (343-4361)  708   (128-3073)  276 (103.9-794.7)  588.8 (86-1423)  57.32  (10.87- 182.0) 
IL-12p40                    9.85  (0.1-52.07)  5.25 (0.1-30.61)  1.16 (0.1-7.8)  1.2 (0.1-6.1)                  3.1   
GM-CSF 747 (284.6-1413) 404 (113-1016) 168.6 (43.54- 453.2) 256 (56- 749) 21.44 (3.8-97.63) 
IL-1                                                      93.67 (13.01-524.5)  58.53 (5.0-332.6)  39.27  (3.8-153.1)  63.71(2.94-298.9)  3.46     (3.1- 73.10) 
IL-10                            77.33 (7-222.1)  49.45 (8.2-152.4)  30.84 (3.8-101.6)  27.60 (4.2-147.9)  6.2        (3.2-48.45) 
MIP-1                      5223 (994.9-9060)  3015 (538.1-8735)  2033  (193.4-6302)  1682 (173.6-6953)  900.9  (93.11-2298) 
MIP-1 2296 (683.4-5799)  1508 (411.7-4773)  824.2 (142.1-2054) 840.7(173-2235)  338.6  (77.40-1098) 

















                     Table 5.03 Comparison of cytokine response following infection of human MDM from different population groups   

































   IQR – Interquartile range between 25th and 75th percentile.  
    Cytokine responses are back ground-subtracted values.
Cytokines            Chinese 
        Median (IQR)  
        Black  
       Median (IQR)               
       Coloured 
      Median (IQR)  
            White 
Median (IQR) 
      Indian  
Median (IQR)  
TNF 1845 (384-4833) 797.4 (210.9-2361) 456.8 (40-2245)  1050 (279.9-3350)  949.5 (309.5- 4419) 
IL-6                              625.5 (147- 2600) 454 (136.3- 2298) 209.1 (27.45 – 758.6)  592 (96.38- 2450)  760.6 (139.5 – 2592) 
IL-12p40                    5.7 (0.1-27.73)  1.22 (0.1- 18.34)  2.24 (0.1- 12.81)  3.49 (0- 33.39)  2.70 (0-29.12) 
GM-CSF                       431.7 (130.8-984)  363.3 (165.7-782.4) 235.3(51.99-1215)  297.5 (71.52-960.9)  307.9 (86.68-942.2) 
IL-1                                                       72.17 (11.33 – 39.4)  47.25 (10.57- 368.3) 15.53 (0-15.53)  65.95(4.2- 309.0)  46 (5.7- 279.4) 
IL-10                            60.44 (12.65-155.0)  48.30 (9.44-148.7)  19.64 (3.17-124.1)  44.42(5.6-179.3)  34.77 (3.8-104.7) 
MIP-1                      4389 (1847-8389)  2454 (472.1-7588)  1558 (66.25- 7609)  2809 (525.6-8814)  2003 (191.2- 6933) 
MIP-1 2146(552.2-3847)  1053 (413.7-2641)  654.4 (26.67-1809)  1233 (395-3454)  1053(106-4065)  















5.4.2 The interaction between M. tuberculosis lineage-induced cytokine 
responses and various human population groups 
 
In order to investigate the lineage-specific effect on cytokine patterns both 
within individual population groups and within the entire study population, 
principal component analysis and linear modelling with ANOVA was 
performed. The coloured population was excluded from individual population 
analysis, as the number of donors was too low to allow robust analysis. The 
analytes identified by ANOVA to have significantly different patterns of 
cytokine production in response to different M. tuberculosis lineages in each 
individual population or in the total study population is presented in Table 
5.04.  
Table 5.04 Analytes identified to be differentially secreted between different 
lineages during macrophage infection in individual population groups or in all 
groups considered cumulatively. 
 
Cytokines All Groups 
 q – value 
(p<0.05) 
Chinese 
q – value 
(p<0.05) 
Black  
q – value 
(p<0.05) 
White 
q – value 
(p<0.05) 
Indian 
q – value 
(p<0.05) 
IL-12p40 7.71x10-14 3.9X10-4 0.01 0.01 9.96X10-3 
GM-CSF 2.60x10-13 7.17x10-07 0.02 0.01 0.03 
Il-6 1.59x10-12 1.21 X10-4 0.01 0.03 9.96X10-3 
TNF 6.01x10-13 1.21X10-4 Ns 5.53X 10-4 9.96X10-3 
IL-1 3.89x10-05 Ns 0.02 Ns Ns 
MIP-1 9.92x10-09 2.22X10-4 Ns Ns 9.96X10-3 
MIP-1 Ns 5.26X10-4 Ns Ns Ns 















# q values represent the false discovery rate, according to the Benjamin-Hochberg 
method. 
Three inflammatory cytokines IL-6, IL-12p40, and GM-CSF were identified to 
be differentially secreted in response to in vitro infection with strains from 
different lineages in MDM from all four-population groups as well as in the 
entire cohort. TNF was also differentially produced in MDM from all 
population groups (and in the total study population) except Black Africans. 
There were four other analytes which showed differences between lineages in 
specific populations: MDM from Black Africans showed differential production 
of IL-1β, MDM from Chinese donors showed a significant difference in MIP-1 
between lineages, whilst MIP-1 and IL-8 levels were significantly different 
between lineages in both the Chinese and Indian populations. Cytokines that 
showed differential production between different M. tuberculosis lineages are 
depicted in a network diagram, Figure 5.12. In this figure, analytes are 
connected to their closest neighbour (that which has the most similar pattern 
of production in response to infection with the various M. tuberculosis strain 
lineages). 
 
Figure 5.12 Three-dimensional network of Principal Component Analysis plot 
showing the M. tuberculosis lineage-induced innate cytokines that were 
differentially expressed between lineages. The component vectors are displayed 















accounted by that component. The distance between the analytes in the network 
represents their Pearson’s correlation coefficient. Analytes are connected with 
their nearest neighbor (the analyte that displays the most similar pattern in 
response to infection with the various strain lineages) and they are colored based 
on their R2 Statistic.  
 
Analytes identified to have significantly different secretion patterns between 
lineages were then visualized using PCA analysis to investigate the correlation of 
patterns between lineages (Figure 5.13), and in different human populations. The 
combined effects of all cytokines included in the analysis determine the position of 
each dot in the PCA plot. Tight clustering of samples indicates greater similarity 
between samples, in terms of the pattern of cytokines produced in response to 
infection. In the PCA plot, component vectors are displayed along with a 
percentage signifying the proportion of the variability in the data accounted for by 
for that component. The three first principal (1, 2, 3) components in Figure 5.12 
and 5.13 were responsible for 68%, 14% and 7% of the variance in the data subset, 
respectively. There is no distinct segregation on the PCA plots, however responses 
to lineage 2 (blue) strains clustered tightly in black and white populations, and, in 
general, away from lineage 4 (red) strains. In contrast, responses to lineage 4 
strains were more dispersed. Responses to all lineages were more tightly clustered 
amongst black donors. The East-Asian (Chinese) and South-Asian (Indian) 
populations showed a more dispersed pattern of lineage-induced cytokine 



















Figure 5.13 Principal component analysis of M. tuberculosis lineage induced cytokine responses in individual population groups [A. Black, B. White, C. 
Indian D. Chinese population, E. All populations combined]. Each dot represents the pattern of cytokine responses in an individual donor. The position of 
each dot is determined by the combined effects of cytokines identified to contribute to significant differences between each lineage.  The distance between 
points represents correlation between points, measured by Euclidean distance. The first 3 principal components are presented together with the 















In another approach, to investigate the interaction between M. tuberculosis strain 
lineage-induced cytokine responses and various human populations; we 
expressed the cytokine response in mean rank order across various lineages and 
population groups. Actual cytokine values were replaced by their rank order 
values and these ranked values were analysed using repeated measures analysis 
of variance to compare cytokine levels among population groups (for each 
individual cytokine), to compare levels in response to different lineages and to 
investigate whether the differential production in response to different lineages 
differed amongst the different population groups.  The mean ra k orders were 
graphed by population group and lineage, with lineage means connected within 
population groups to give a visual impression of the lineage-specific responses 
within each population group (Figure 5.14).  
The TNF response showed a clear pattern of lineage effect - mean rank order: 
(lineage 4> lineage 3> lineage 1 > lineage 2; p<0.001). There was no significant 
population effect (p=0.42), nor was there evidence of lineage-population 
interaction (p=0.38). Virtually identical patterns to those found in TNF were 
observed for IL12p40.  
There was a possible interaction between lineage and different population 
groups for IL-6 responses (p= 0.07). Lineage 4 strains displayed highest mean 
rank order across the population groups but responses to lineage 3 strains were 
variable amongst the population groups, with low rank order in the Black 
population and high rank order in the Indian population.  
The IL-1 response showed similar pattern of mean rank order of the 3 modern 















population groups. However, interestingly, ancient lineage 1 strains showed a 
different pattern amongst both Indian and Chinese populations, having high 
mean rank order in these populations, however the overall interaction between 
lineage and population group was statistically not significant (p= 0.42). There 
was no significant population effect in IL-1 response (p=0.60). 
For GM-CSF there was a clear lineage-specific response similar to that for TNF 
(mean rank order: lineage 4> lineage 3> lineage 1 > lineage 2; p<0.001) however 
there were no population or lineage-population specific effects.  
The IL-10 response demonstrated a similar pattern of mean rank orders across 
the Chinese, White and Indian population groups (lineage 4 > lineage 3 > lineage 
2/1). However, a different pattern was observed amongst black and coloured 
populations, where lineage 3 and 4 showed similar rank orders to lineages 1 and 
2.  However, the interaction between lineage and population group was not 
statistically significant (p=0.30).  
The chemokine MIP-1 showed large lineage-specific differences in the Chinese 
population, whilst in contrast, amongst the Black population, there were no 
differences in response to infection between different lineages. However, these 
differences in response were not statistically significant (p=0.32). MIP-1 
responses followed a similar pattern to TNF, with a clear lineage-specific effect 
(p<0.05) but no interaction between population and lineage. Patterns of IL-8 
response differed across all population groups, with no consistent lineage-
specific effect, in contrast to most of the other cytokines assayed. No population 















Figure 5.14 Graphs showing the interaction between M. tuberculosis lineages 
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Studies linking epidemiological information with sequence-based phylogenies 
suggest that M. tuberculosis strain lineages are strongly associated with 
geographical location and that lineages may have adapted to specific human 
populations169. Further, different genotypes of M. tuberculosis have been reported 
to exhibit different patterns of host immune response in in vitro and in vivo 
infection models129, 133, 137, 138, 216, 237, but the relevance of these findings to the 
apparent association between strain lineage and host population group is not 
clear. 
Immune triggering commences with interaction between mycobacterial cell 
surface components and various receptors present on host macrophages and 















cytokines play a key role in both enhancing the innate immune response as well 
as coordinating adaptive responses, which are likely to influence bacterial 
clearance or persistence in the host. Thus, type-1 cytokines (TNF, IFN-, IL-12 
and GM-CSF) are inflammatory287, 316 and enhance macrophage activity whilst 
type-2 or regulatory cytokines (eg. IL-10) may suppress anti-microbial activity 
during M. tuberculosis infection93.  
Here, we investigated different M. tuberculosis strain lineage-induced cytokine 
and chemokine responses in MDM isolated from a wide range of healthy blood 
donors, and their interaction, across five human ethnic groups. We measured 
several pro-inflammatory and regulatory cytokines and chemokine following 
MDM infection with strains from three modern lineages and a strain from an 
ancient lineage (lineage 1) by multiple cytokine assays. Additionally, we explored 
possible interactions between M. tuberculosis lineage induced cytokine responses 
and human ethnic groups. 
We observed that MDM infected with lineage 4 strains and lineage 3 strains 
induced higher levels of pro-inflammatory cytokines- TNF, IL-6, IL-1, GM-CSF, 
IL-12p40 while the pro-inflammatory cytokine secretion by lineage 2 strains was 
lower than the other two modern lineages, supporting the findings of previous 
researchers (described in Chapter 2), who studied individual strains in small 
numbers of donors137, 138, 216, 224, 237. A clinical study reported that Vietnamese 
adult TBM patients infected with lineage 4 strains have lower mortality than 
those infected with lineage 2 and lineage 1 strains307. This finding is supported by 
rabbit infection studies which showed that a lineage 4 strain was highly 















mild focal inflammation of the meninges and minimal infiltrate even in presence 
of high bacillary loads 131.  
Further, we observed that an ‘ancient’ M. tuberculosis lineage 1 strain induced 
intermediate levels of TNF and IL-6, lower than lineage 4 and lineage 3 strains, 
but higher than lineage 2 strains. A clinical study from Vietnam also observed 
that lineage 1 strains induce low levels of several cytokines (IFN-, TNF, IL-10, IL-
6, IL-8) in cerebrospinal fluid (CSF) of Vietnamese TBM patients. Lineage 1 and 
lineage 2 strains were closer in cytokine phenotype when compared with lineage 
4 strains303. Lineage 4 strains were reported to produce elevated levels of these 
cytokines in CSF303. In contrast, another study reported higher inflammatory IFN-
 production in PBMC by ancient lineage 1 strains than the modern strain 
lineages [lineage 3 and lineage 2 strains]289. However, Portevin et al. reported 
that the ancient group of strains exhibit more heterogeneity in inflammatory 
cytokine response than the modern strain lineages, suggesting ancient lineage 1 
strains might also vary in virulence217. It should be noted that lineage 1 strains 
are prevalent in the Indian subcontinent.  
 Our study was restricted to a limited number of strains from each lineage. One 
other study has reported that there is variability within lineages with regard to 
inflammatory phenotype with small numbers of strains exhibiting divergent 
inflammatory phenotypes217. The reason behind such divergence is not yet clear.  
In general, absolute levels of IL-12p40 induction were found to be low during M. 
tuberculosis infection in our model. Similarly, we observed low levels of IL-1 
induction following MDM infection with M. tuberculosis. We used a low MOI (1:1) 















tuberculosis with higher MOI (10:1) induced high levels of IL-1 whilst low MOI 
(1:1) induced no or small amounts of this cytokine317. IL-1 induction is 
facilitated by activation of caspase 1, which causes apoptosis of infected 
macrophages318. The study has found that high MOI triggered the induction of 
caspase-1 dependent early IL-1 secretion. This study concluded that virulent 
mycobacteria are able to multiply to higher numbers inside macrophages by 
controlling IL-1 secretion and triggering ESAT-6 dependent necrosis rather than 
apoptosis317.  
The cytokine IL-12 is essential for development of Th1-mediated protective 
immunity in tuberculosis infection193, 289, 298. We found that M. tuberculosis 
infected macrophages produced low levels of cytokine IL-12p40 in our model 
system, irrespective of the infecting strain or host population, although there was 
still a clear lineage-specific pattern of responses (lineage 4 > 3 > 2/1).  
IL-10 is an important regulatory cytokine involved in suppression of function 
of macrophages and dendritic cells and inhibition of TNF and IL-12 production, 
resulting in reduced Th1 response319, 320. IL-10 knock-out mice show reduced 
bacterial load in mice and increased CD4+T cells as well as various Th1 
cytokine and chemokines (IFN-, TNF, IL-6, GM-CSF, IP-10, IL-17)321, 
suggesting that IL-10 could regulate the early Th1 response and that 
neutralization of IL-10 during vaccination may improve protective immunity. 
We found that lineage 1 and 2 strains induced lower levels of IL-10 than 
lineage 4 strains, however these strains also induced relatively low levels of 
Th1 cytokines, so there was no clear evidence of an inverse relationship in this 
study. We also evaluated various chemokine responses in MDM infection with 















contain mycobacterial proliferation and is considered an essential event in the 
host immune response. Chemokines facilitate granuloma formation by 
recruiting monocytes, naive lymphocytes, and Th1 cells into the infected 
tissues from the blood stream. These chemokines are chemo-attractant 
proteins, which are produced by lymphocytes, macrophages, and neutrophils. 
The beta chemokines (MIP-1 and MIP-1) are important in macrophage 
activation and proliferation of T cells. Another chemokine, IL-8 is produced by 
macrophages and facilitates recruitments of neutrophils, lymphocytes, and 
monocytes to sites of infection322, 323. The virulence of M. tuberculosis strains 
has been found to be associated with beta chemokine (eg. MIP-1 and MIP-1) 
induction in infected macrophages: insufficient induction of chemokines during 
M. tuberculosis infection may cause deficiency in the acquired immune 
response, and MIP-1 and RANTES in combination enhance killing of M. 
tuberculosis324. We observed differential induction of MIP-1, which was lower 
in MDM, infected with lineage 2 strains than lineage 3 or 4 strains. The 
depression in chemokine response may impair Th1 cell migration to infection 
sites, resulting in poor granuloma formation and failure in bacterial 
containment324. This finding correlates with animal models showing 
disseminated infection with lineage 2 strains129, 131, 135. 
The cytokine network from PCA plots further confirmed that the inflammatory 
cytokines (IL-6, IL-12p40, GM-CSF and TNF) are differentially secreted by MDM 
infected with different lineages and share the closest patterns of production 
across the various population groups. Earlier studies reported that successful 
outbreak strains induce certain inflammatory cytokine responses poorly, which 















Therefore, variation in inflammatory cytokine response between lineages may be 
relevant for tuberculosis disease outcomes. Such divergence in inflammatory 
response across the lineages is likely to be a combined effect of genetic 
polymorphisms in strain lineages and host innate immune related genes.  
Studies examining the interaction between M. tuberculosis and the human host 
have predicted that certain strain lineages may acquire a selective advantage 
within particular population groups, which may result in increased severity of 
disease or high prevalence within certain human populations307-310.  
Polymorphisms in host innate immune genes have been reported to be associated 
with higher susceptibility to certain M. tuberculosis lineages34-36.  For example, 
polymorphism in the TIRAP (C558T) and TLR2 (T597C) genes were found to be 
associated with TBM rather than the pulmonary tuberculosis in Vietnamese 
tuberculosis patients307. This effect was modified by strain genotype, TBM 
patients with polymorphism in 597C allele of TLR2 gene were more likely to have 
tuberculosis caused by lineage 2 strains307. However, further studies are needed 
to demonstrate interactions between host population and M. tuberculosis lineages 
in other population groups.  
In order to investigate whether inflammatory responses differ between 
population groups, we compared cytokine responses in M. tuberculosis infected 
MDM between population groups (irrespective of M. tuberculosis strain lineages) 
as well as the interaction between lineage-induced cytokine responses and the 
population groups.  
In comparison to variation associated with different lineages of M. tuberculosis, 















levels were lower in the Coloured population as compared to Chinese population. 
TNF plays an important role in maintenance and control of tuberculosis by 
granuloma formation325. Previously, studies have been reported that a functional 
single nucleotide polymorphism (-360 G > A, rs1800629) in the TNF promoter is 
associated with tuberculosis disease susceptibility326, 327. A case control study has 
reported that variation in the 3’ untranslated region of the TNFR1B gene (GTT 
haplotype) is associated with tuberculosis disease susceptibility in South African 
Coloured and Ghanaian female populations328. Further, it has been reported that 
GTT haplotype is involved with TNFR2 mRNA decay, causing destabilization of 
TNF and increased susceptibility to tuberculosis328. There was no evidence of 
interaction between M. tuberculosis lineage and population group in our infection 
model, with regard to TNF production. 
 IL-6 is produced by varieties of cells such as macrophages, T cells, endothelial 
cells, and fibroblasts. IL-6 is a pro-inflammatory cytokine that induces acute 
phase proteins during infection with M. tuberculosis. IL-6 also has inhibitory 
effect on macrophages and inhibits production of LPS-induced TNF in peripheral 
blood monocytes329. We found lower (but not significantly so) levels of IL-6 in the 
Coloured population as compared to other population groups. Hawn et al. 
reported that a heterozygous state for the 558C-T SNP was associated with low 
levels of IL-6 induction and TBM in a Vietnamese population53. Recently, a case 
control study on South African mixed ancestry (Coloured) and Xhosa populations 
demonstrated that the 558C-T allele was associated with TBM in South Africans  
mixed descent but the study found no association with TBM in the South African 
Black (Xhosa speaking) population330. It should be noted that the Coloured 















mechanism that is responsible for the association of TBM with the 558C-T 
polymorphism in certain human populations is unknown. The 558 polymorphism 
is synonymous hence, is unlikely to result in amino acid modification.  However, 
synonymous SNPs have been reported to cause alteration in mRNA folding 
resulting in structural alteration and change in protein expression levels332.  
Our study may not have been sufficiently powered to fully demonstrate 
interactions between lineages and population groups. However several possible 
interactions were identified. Interestingly, MDM infected with lineage 3 strains 
showed higher mean rank order of IL-6 in the Indian population than the South 
African black population. This finding is consistent with previous findings that a 
lineage 3 outbreak strain (CH) induced more anti-inflammatory cytokine IL-10 
and IL-6 resulting in reduction in IL-12p40 secretion138. Lineage 3 strains are 
prevalent on the Indian subcontinent and uncommon in South Africa. Studies 
have demonstrated a significant increase of IL-6 level in active pulmonary 
tuberculosis and tuberculosis pleurisy333 and in bronchoalveolar lavage of active 
tuberculosis patients and alveolar macrophages isolated from tuberculosis 
lesions334. IL-6 interferes with IFN- mediated signals in virulent mycobacterial 
(H37Rv) infection. THP1 cells infected with H37Rv induced IL-6 in a time 
dependent manner and blocking of IL-6 by anti-IL-6 antibody significantly 
enhanced IFN- mediated killing of bacteria. IL-6 inhibits autophagolysome 
formation by inhibiting the Atg12-Atg5 complex335 (autophagy-related protein). 
Thus, increase in IL-6 response in MDM infection with lineage 3 strains of M. 
tuberculosis may responsible for skewing of the innate immune response and 
increased susceptibility to lineage 3 strains in individuals of Indian origin. On the 















been reported to be associated with differential expression of IL-6 in tuberculosis 
and other inflammatory diseases336. Mutation in the IL-6 promoter region (-174, 
change of G>C allele) has been found to cause reduced in IL-6 levels in M. 
tuberculosis infection336 in Iranian patients. Studies of other diseases (e.g., 
chronic arthritis) have reported that the G allele is associated with higher levels 
of IL-6 response337 and that C allele frequencies were found to be extremely low 
in Asian populations (Chinese and Indian). As a result these population groups 
produce elevated IL-6 responses, which is consistent with our findings337, 338.  
IL-10 responses in African Black and Coloured populations were remarkably 
similar across all strain lineages; suggesting uniform IL-10 induced anti-
inflammatory activity for all M. tuberculosis lineages in these two population 
groups (in contrast to the other population groups, where a more clear effect of 
lineage was observed).  
In our study, there was a particularly clear effect of lineage on the induction of 
MIP-1 in the Chinese population. We also observed that MIP-1 secretion 
during in vitro M. tuberculosis infection was higher in Chinese population. MIP-1 
polymorphisms have been found to be important in global susceptibility to HIV 
infection339. A bi-allelic dinucleotide microsatellite repeat (TA) has been 
identified in the promoter region (-906) of MIP-1 gene in Chinese Population. 
This polymorphism (MIP-1α −906 (TA) 6/(TA) 6) is associated with higher level 
of MIP-1 secretion in several inflammatory diseases340-342. This allele is common 
in the Chinese population, and is associated with increased susceptibility to 
various inflammatory diseases such as ulcerative colitis and Alzheimer’s 















been reported in tuberculosis patients. The distribution of another functional 
single nucleotide polymorphism of MIP-1α (MIP-1 α+459 C/T) was tested in TB 
and healthy control subjects of Hong Kong Chinese population but there was no 
association found343.  
IL-8 responses were interesting in that, unlike most of the other cytokines, there 
was no clear lineage-specific pattern across the different population groups. In 
black and white populations there were similarities in the mean rank order in 
which IL-8 response was slightly increased with lineage 2 strains. In addition, as 
with MIP-1α responses, IL-8 responses in the black population were remarkably 
homogeneous across different strain lineages. It has been reported that a 
polymorphism in IL-8 promoter region (IL-8-251T>A) is responsible for variation 
in IL-8 level. The IL-8-251A homozygous allele was found to be associated with 
increase in IL-8 response in tuberculosis cases in white and African-American TB 
patients when compared with healthy controls344. It has been reported that the 
IL-8251A allele is more prevalent in the South African Black population than the 
South African white population (allelic frequency 0.41 in White and 0.85 in 
Black)345, which was proposed as a possible reason for increased susceptibility to 
tuberculosis in the South African Black population. However we did not 
demonstrate increased IL-8 response in the Black population.  
Black donors in this study were significantly older than donors from other ethnic 
groups. Although we are not aware of any specific literature describing 
differences in age-specific host responses to M. tuberculosis, it is possible that 















It should be noted that the median levels of TNF and IL-12p40 detected in 
experiments described in Chapters 4 and 5 differ substantially. This is likely due 
to a number of differences in experimental design. Experiments in chapter 4 were 
performed with a small number of donors (n=8) whereas chapter 5 included 
large number of donors (n= 69). The experimental sets up of two chapters were 
also quite different as the donors selected in chapter 4 were anonymous and it 
was from buffy coats supplied by South African Blood Transfusion Services. In 
Chapter 5 monocytes were isolated from defined blood donors of differing 
ethnicity. Further, in chapter 5, monocytes were isolated immediately after 
collection of blood. Moreover, the difference in median cytokine level in TNF and 
IL-12p40 could be also due to different assay sensitivities as the measurements 
of cytokine response were performed using two different platforms (Luminex vs. 
ELISA).  
In Summary, we observed that lineage 4 strains and lineage 3 strains induced 
higher levels of pro-inflammatory cytokines- TNF, IL-6, IL-1, GM-CSF, IL-12p40 
when compared to lineage 2 and lineage 1 strains We also observed that three 
inflammatory cytokines (IL-6, IL-12p40, and GM-CSF) were differentially 
secreted in response to in vitro infection with strains from different lineages in 
MDM from all four-population groups (Chinese, Black, White and Indian), 
suggesting that this is a conserved pattern of response unrelated to host 
ethnicity. TNF and IL-6 response was lower in the coloured population. IL-6 
responses were particularly variable after infection with lineage 3 strains, with 
responses was highest in the Indian population group and lowest in the black 
population group. Possible strain lineage-host ethnicity interactions were also 















In conclusion, polymorphism in either the bacterial genome or in the host 
immune system may influence the induction of cytokine responses in M. 
tuberculosis infection. The variation observed in M. tuberculosis lineage-induced 
immune responses in specific populations might partly explain the observed 















    Chapter 6 





































Summary and future work 
 
Host and bacterial genotypes are both important determinants of tuberculosis 
disease progression, with the interaction between M. tuberculosis and the host 
innate immune system playing a central role53, 292, 346. The first part of the work 
presented in this thesis focuses on how strain variation in M. tuberculosis 
influences different virulence-associated characteristics including intracellular 
growth in macrophages, growth in axenic media and early cytokine response in 
an experimental model of intracellular infection.  The second part of the thesis 
focuses on the interaction between M. tuberculosis strain lineages and different 
human ethnic groups by exploring induced cytokine and chemokine responses 
during in vitro infection of human MDM.  
The first experimental chapter, chapter 3, describes experiments comparing the 
fitness of different strains of M. tuberculosis as measured by in vitro growth 
phenotypes in axenic media and MDM. We compared the laboratory reference 
strain (H37Rv) with eight strains from the three modern lineages [Lineage 4 (3 
strains), Lineage 3 (2 strains), Lineage 2 (3 strains)]. In axenic media, lineage 4 
strains demonstrated growth to a higher plateau than strains from the two other 
lineages. Lineage 3 strains grew relatively poorly, whilst lineage 2 strains showed 
an intermediate growth phenotype. The laboratory reference strain (H37Rv) 
grew more rapidly and to a higher level than all clinical strains, suggesting 
adaptation to growth in axenic media. Intracellular growth patterns were 
somewhat different, with lineage 2 strains and lineage 4 strains following very 
similar patterns of growth. Lineage 2 strains grew significantly more rapidly than 















suggest that modern lineages of M. tuberculosis appear to vary in terms of their 
growth phenotype in both intracellular and cell free systems.  
In chapter 4 we measured early induction of two key pro-inflammatory 
cytokines, TNF and IL-12p40 in human MDM infected with different modern 
strains of M. tuberculosis. Patterns of cytokine induction by the three modern 
lineages were distinct and different, with lineage 4  strains inducing high levels of 
both cytokines, lineage 2  strains low levels of both cytokines and lineage 3 
strains high levels of TNF but low levels of IL-12p40. In order to further 
investigate whether the immune response to strains from different genotypes 
was influenced by the population group of the host, we performed a cross 
sectional study in chapter 5 in which MDM from donors of varying ethnicity were 
infected with M. tuberculosis strains from different lineages. We firstly found that 
the inflammatory cytokines response (TNF, IL-12p40, IL-6, IL-1 and GM-CSF) 
differs across the lineages (independent of host ethnicity), where lineage 4 and 
lineage 3 strains induced higher levels of these cytokines as compared to lineage 
2 and lineage 1 strain. W  also found that three inflammatory cytokines (IL-6, IL-
12p40, and GM-CSF) were differentially secreted in response to in vitro infection 
with strains from different lineages in MDM from all four-population groups 
(Chinese, Black, White and Indian), suggesting that this is a conserved pattern of 
responses unrelated to host ethnicity. TNF and IL-6 levels were lower in the 
Coloured population, which supports previous findings328, 330. We also observed 
high levels of induction of MIP-1, which has previously been shown to be 
increased in Chinese patients with other inflammatory conditions340-342. Although 
the study may have been underpowered to detect interactions between lineages 















such interactions. For example, IL-6 induction in response to infection with 
lineage 3 strains varied by population group, being highest in MDM from Indian 
donors, and lowest in MDM from Black African donors. In contrast, IL-6 induction 
in response to infection with other strain lineages was independent of host 
population. This finding is of interest, since lineage 3 strains predominate on the 
Indian subcontinent.  
In conclusion, our findings suggest that there are M. tuberculosis lineage-specific 
patterns of growth and cytokine induction and that pattern of cytokine induction 
may be influenced by host ethnicity.  These findings may have important 
implications for rational vaccine design, since innate immune responses to BCG 
vaccine itself are likely to differ according to ethnicity of the recipient, which 
may, in turn, affect acquired memory responses. In addition, differences in such 
patterns of response may have important implications for disease pathogenesis, 
affecting important disease outcomes such as the proportion of M. tuberculosis 
infections that progress to active tuberculosis. 
Our study was limited to selected strains from particular lineages. Further 
studies with collections of strains from elsewhere will be important to confirm 
and extend our findings. It would further be important to explore in more detail 
whether sub-lineages (within these major lineages) differ in terms of the 
virulence-associated characteristics assessed in these studies.  
The relatively small number of donors limited our study exploring the interaction 
between host and bacterial genotype. However, studies of this kind are very 
labour and resource intensive. We have identified several potential interactions, 















and which may provide further clues as to the reasons for the strong 
phylogeographic signal in the global distribution of M. tuberculosis lineages and 
the apparent association between particular lineages and host population groups. 
Such studies may identify effective immune pathways for control of M. 
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